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Bo Xu
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Plenary lectures
Anti-platelet Dilemma

Ze-ning Jin

Dual Therapy Stent

Michael Haude

Rde of Antiplatelet Therapy in Management
of STEMI Patient - Local Experience

Frankie Tam

Advanced Echocardiography Analysis for Diagnosis
and Patient Management

Kelvin Kai-hang Yiu
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Coffee Break & Visit Exhibits
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PCi Cases discussion
Prize Presentation
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1500 - 1600
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Novel Anticoagulants: Current Issues and Practical Tips Jeffrey Wing-hong Fung
in Management of Atrial Fibrillation Patients
Taking DES Technology from Concept to Clinical
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Ronald Chi-heng Li
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ECG in Sudden Cardiac Death

Ngai-shing Mok

How to Avoid Implantable Lead Failure?

Ngai-yin Chan
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Computed Tomography Heart of Tomorrow Track

Stephen Chi-wai Cheung

1730 - 1830

Ming ii room

When Cardiac Magnetic Resonance Complements
Other Modalities: Case Review
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Sung Room

J HK Coll Cardio, Vol 20 (Suppl 1)

Carmen Chan

Farewell Dinner

April 2012

v

Paediatric Cardiology Symposium
Saturday, 5 May 2012
0900 - 1030 Ching room

Paediatric Cardiology Symposium i
Chairpersons: Kai-tung Chau
NB Ling
Hybrid Procedures in Congenital Heart Disease

Frank Ing

Experimental Study of the Mechanical Properties and
Biodegradation Rate of the New Iron Stent for the
Treatment of Great Artery Stenosis

Kun Sun

Postoperative Arrhythmia in Patients with CHD

Fen Li

1030 - 1100 Terrace of
Sung Room

Coffee Break & Visit Exhibits

1100 - 1200 Ching room

Paediatric Cardiology Symposium i
Chairpersons: Lok-yee So
SB Chen

1200 - 1245 Ching room

Surgical Management of CHD in Neonates: Current
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Anticoagulation Strategy after Fontan-type Procedures

Yiu-fai Cheung

Transcatheter Closure of Perimembranous Ventricular
Septal Defect (VSD)

Hui-shen Wang

Free Paper Session
Paediatric Cardiology I
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Opening Ceremony
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Paediatric Cardiology Symposium ii
Chairpersons: Tak-cheung Yung
YF Li
Interventions in Neonates and Infants with Congenital
Heart Disease

Frank Ing

Transcatheter Device Closure of Perimembranous
Ventricular Septal Defect: Fudan Experience

Fang Liu

Diastolic Heart Failure with Preserved Ejection
Fraction in Pediatric Patients

Kin-sing Lun

1600 - 1630 Terrace of
Sung Room

Coffee Break & Visit Exhibits

1630 - 1740 Ching room

Free Paper Session
Paediatric Cardiology II
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ABSTRACTS
Abstracts for Free Paper Session:
COrOnary arTery diSeaSe
1.

Association between polymorphism of methylenetetrahydrofolate reductase (MTHFR)
C677T and risk of myocardial infarction: a meta-analysis for 8,140 cases and 10,522
controls
Chao Xuan1, Xiao-Yan Bai1, Ge Gao1, Qin Yang1, 2, Guo-Wei He1, 3
1
TEDA International Cardiovascular Hospital, Medical College, Nankai University, Tianjin,
PR China
2
The Chinese University of Hong Kong, Hong Kong, PR China
3
Department of Surgery, Oregon Health and Science University, Portland, Oregon, U.S.A

2.

The Relationship between Waist Circumference and Glycated Hemoglobin in the
United States
N. R. Samaranayake1, C. Li1, K.L. Ong2, 3, B. M. Y. Cheung1
1
Department of Medicine, University of Hong Kong, Hong Kong
2
Lipid Research Group, Heart Research Institute, Sydney, NSW, Australia
3
Department of Medicine, University of Sydney, NSW, Australia

Purpose: The methylenetetrahydrofolate reductase (MTHFR) gene C677T polymorphism
has been reported to be associated with myocardial infarction (MI), but the results from
previous studies were conflicting. The present study aimed at investigating the association
between this polymorphism and risk of MI using a meta-analysis on the published studies.
Methods: The Medline, EBSCO, BIOSIS, and Cochrane Library were searched to
identify eligible studies published in English before August, 2011. Data were extracted
using standardized methods. The association was assessed by odds ratio (OR) with 95%
confidence intervals (CI). Begg’s test was used to measure publication bias.
Results: A total of 30 case-control studies, containing 8,140 MI cases and 10,522 controls
were involved in this meta-analysis. Overall, significant association was found between
MTHFR C677T polymorphism and risk of MI when all studies pooled with fixed-effects
model for TT vs. CT (OR = 1.183, 95% CI: 1.076 – 1.300). In the subgroup analysis, the
same association was found in overall Caucasians (OR = 1.139, 95 % CI: 1.007 – 1.288)
and young/middle-aged (< 50 years) Caucasians (OR = 1.275, 95 % CI: 1.077 – 1.509). No
associations were detected between MTHFR C677T and the risk of MI in old-aged, male,
female Caucasians, East Asians, South Asians, and African-Americans.
Conclusions: The meta-analysis results suggest that the MTHFR C677T polymorphism
was associated with risk of MI in young/middle-aged Caucasians. The effect of the variants
on the expression levels and the possible functional role of the variants in MI should be
addressed in further studies.

Purpose: Obesity leads to type 2 diabetes, an important risk factor for cardiovascular
disease. As glycated hemoglobin (A1C) can now be used for the diagnosis of diabetes, we
studied the relationship between A1C and waist circumference.
Methods: 1806 men and 1734 women over the age of 20 years in the United States
National Health and Nutrition Examination Survey 2005-2008 who had fasted overnight
and were not on medication for diabetes were included for analysis. A1C levels of 5.7%
and 6.5% were used as cut-offs for pre-diabetes and diabetes respectively.
Results: The waist circumference had a linear association with A1C in both men (P=0.001)
and women (P<0.001). An A1C level of 5.7% corresponded to a waist circumference of
98.4, 102.4 and 106.4 cm in men and 96.1, 96.6 and 97.0 cm in women at ages 30, 50 and
70 respectively. An A1C level of 6.5% corresponded to a waist circumference of 101.5,
105.4 and 109.4 cm in men and 103.4, 103.9 and 104.4 cm in women at ages 30, 50 and
70 years respectively. The waist circumference increased significantly with age in men
(P<0.001) but only slightly in women. The linear relationship between waist circumference
and A1C was seen in all non-Hispanic whites (men, P=0.013; women, P<0.001), nonHispanic blacks (men, P<0.001; women, P=0.013), and Mexican American women
(P=0.001).
Conclusions: A1C level increases linearly with waist circumference. A smaller waist
circumference corresponds to a lower A1C level in both men and women. This association
is seen among all ethnic groups except Mexican American men. In men, the waist
circumferences associated with pre-diabetes and diabetes change with age. Our results
reveal that younger American men with a waist circumference below 100 cm are already at
risk of pre-diabetes.
Acknowledgment: Support from the Faculty Development Fund is gratefully acknowledged

3.

4.

Glycaemic Control and Extent of Cardiovascular Disease
C.L. Lau1, P.T. Tsui1, C.L. Lau1, N.Y. Chan1, C.C. Choy1, D. Chow1, J. Chu1, H.C. Yuen1, D.
Fong1, N.S. Mok1, S.T. Lau1
1
Department of Medicine and Geriatrics, Princess Margaret Hospital, HKSAR
Objectives: Diabetic patients are known to have more extensive coronary artery disease and
more frequent concomitant non-coronary macro-vascular or micro-vascular complications
than non-diabetic patients. This study aimed to study the relationship between glycaemic
control and extent of cardiovascular diseases.
Methods: This was a retrospective case series study conducted in cardiac intervention
center of Princess Margaret Hospital on patients who had percutaneous coronary
intervention (PCI) in 2010.
Results: Five hundred and eleven consecutive patients (18% female, 82% male) of age
63+/-11 were recruited. Underlying cardiovascular risk factors were diabetes (38%),
hypertension (62%), hyperlipidemia (87%), current or history of smoking (46%). Sixty
percent of PCI patients presented with acute myocardial infarction (AMI) without prior
history of typical angina. Thirty-six percent presented with typical angina with or without
AMI. Four percent were totally asymptomatic. Twenty-eight percent had HbA1c>8%.
Diabetic patients were more likely than non-diabetics to have 3-vessel disease (3VD) [39%
versus 24%], peripheral vascular disease (PVD) [5% versus 1%], cerebrovascular disease
(CVD) [12% versus 5%], and creatinine>120umol/L (CRI) [25% versus 5%]. Eighty
percent of diabetics and 52% of non-diabetics had concomitant hypertension. Diabetic
patients with HbA1c>8% were more likely than diabetic patients with HbA1c<=8% to have
3VD (54% versus 34%), PVD (6% versus 4%), CVD (17% versus 9%), and CRI (35%
versus 24%). By multivariate analysis, diabetes was an independent correlation factor of
CRI and extensive macro-vascular complications (3VD, PVD, CVD). Among diabetic
patients, HbA1c>8% was an independent correlation factor of CRI and extensive macrovascular complications (3VD, PVD, CVD)
Conclusion: Diabetic patients, especially those with HbA1c>8%, are more likely to have
extensive macro-vascular complications and concomitant chronic renal impairment than
non-diabetics.
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Longitudinal Strain Predicts High Risk Patients with Acute Coronary Syndrome
W. C.W. Lam1, L. Cheung1, T. Liu1, M. Tang1, K. W. Chan1
Division of Cardiology, North District Hospital

1

Background: Myocardial strain is an advance echocardiographic parameter for left
ventricular (LV) myocardial function assessment. The aim of this study is to evaluate the
role of two-dimensional longitudinal strain in risk stratification in acute coronary syndrome
(ACS).
Methods: In addition to standard two-dimensional (2D) transthoracic echocardiography,
speckle-tracking derived strain analysis was performed in ACS patients admitted to
North District Hospital (NDH). Global longitudinal peak systolic strains (GLPSS) were
analyzed in 78 ACS patients and 20 normal control subjects. Coronary angiograms and
subsequent revascularization were performed in all 78 ACS patients. Angiographic and
echocardiographic findings were compared.
Results: ACS patients were categorized into 4 groups according to their angiographic
findings, single vessel disease (1VD), double vessel disease (2VD), triple vessel disease
(3VD), and significant left main disease (LMD). Smokers and diabetics were significantly
more prevalent in 3VD and LMD groups. There was statistically significant reduction in
ejection fraction and GLPSS in 3VD and LMD patients (see table).
Control
(N=20)
68.83 ±
7.45

Minor
1VD
2VD
(N=11) (N=37) (N=18)
55.25 ± 53.49 ± 54.17 ±
EF
18.87
11.55
12.07
4.84 ± 4.74 ±
LVEDD
NA
4.2 ± 059
0.73
0.87
1.40 ± 1.39 ± 1.38 ±
WMSI
1.0
0.65
0.43
0.39
-21.08 ± -15.82 ± -15.03 ± -14.67 ±
GLPSS
3.2
6.86
4.2
3.86

3VD
LM
(N=12) (N=6)
48.67 ± 45.67 ±
21.3
16.57
5.38 ± 5.25 ±
1.03
1.02
1.68 ± 1.66 ±
0.65
0.61
-12.67 ± -13.0 ±
3.75
4.38

P
0.000
0.000
0.001
0.000

Conclusion: Patients with high risk coronary stenosis, as defined as triple vessel disease
and left main disease, had lower global longitudinal peak systolic strain values. This
phenomenon may enable clinicians to identify high risk ACS patients, particularly those
with no obvious regional wall motion abnormality on 2D echocardiography.
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Comparing Percutaneous Coronary Intervention and Thrombolysis in Patients with
Return of Spontaneous Circulation after Out-of-hospital Cardiac Arrest
X. Li1, Y.Q. Li1, X.X. Liao1, C.L. Hu1, R. Liu1, H.Y. Wei1
The Department of Emergency of the First Affiliated Hospital, Sun Yat-sen University,
People’s Republic of China

1

Aims: To evaluate the effect of percutaneous coronary intervention (PCI) or thrombolysis,
in patients with return of spontaneous circulation(ROSC) after out-of-hospital cardiac
arrest(OHCA), in the presence of ST-elevation myocardial infarction(STEMI).
Methods: We performed a meta-analysis of clinical studies located in PUBMED and
MEDLINE databases from January 1995 to October 2011. The hospital discharge and
neurological recovery rates, of patients with and without PCI or thrombolysis, were
assessed in patients with ROSC after OHCA in the presence of STEMI. Furthermore,
we also compared the differences in hospital discharge and neurological recovery rates
between patient groups who received PCI or thrombolysis.
Results: The meta-analysis showed that the rate of hospital discharge and neurological
recovery improved with both PCI and thrombolysis in patients with ROSC after OHCA, in
the presence of STEMI. We also found that there were not significant differences between
with PCI and with thrombolysis in the rate of hospital discharge and neurological recovery
for the patients with ROSC after OHCA.
Conclusion: In patients with ROSC after OHCA in the presence of STEMI, both PCI and
thrombolysis improved hospital discharge and neurological recovery rates. Furthermore,
there were similar efficacy in hospital discharge and neurological recovery rates between
with PCI and with thrombolysis.
Keywords: meta-analysis, out-of-hospital cardiac arrest, return of spontaneous circulation,
ST-elevation myocardial infarction, percutaneous coronary intervention, thrombolysis.

A2

April 2012

J HK Coll Cardio, Vol 20 (Suppl 1)

HK College of Cardiology, Twentieth Annual Scientific Congress
ABSTRACTS
Abstracts for Free Paper Session:
PerCuTaneOuS COrOnary inTerVenTiOn (i)
5.

Transradial Approach for Coronary Angiography and Percutaneous Coronary
Intervention in the Hong Kong Sanatorium and Hospital Cardiac Catheterization &
Intervention Centre
S.L. Kan1 and S. E. Lim1, C. Huie1, V. Kwok1
1
Hong Kong Sanatorium and Hospital Cardiac Catheterization & Intervention Centre
Purpose: There has been progressive acceptance of the transradial approach for
coronary angiography and percutaneous coronary intervention (PCI) in the last few
years. Internationally, approximately 20% of procedures are performed using the radial
route as this approach has demonstrated a consistent reduction in bleeding and vascular
complications. In particular, primary PCI using radial artery access is associated with lower
short-term mortality, reduced access site bleeding complications (haematomas) as well
as a lower risk of myocardial infarction. Longer procedure times however have limited
utilization in some countries, though transition of a catheterization laboratory to a preferred
radial approach is feasible. The Hong Kong Sanatorium and Hospital (HKSH) Cardiac
Catheterization Laboratory has embraced the use of the transradial approach for both
diagnostic and therapeutic cardiac catheterization procedures and implemented this change
in 2004. This presentation summarizes the data collected from 2004 to 2008.
Methods: A data collection form consisting of the type of approach, procedure performed,
vessels involved, type and size of sheath used and major complications was filled in by
the cardiac catheterization nurse prior to the performance of the diagnostic or therapeutic
procedure in the cardiac catheterization laboratory. Analysis was made on the forms
received from 2004 to 2008.
Results: From 2004 to 2008 the HKSH Cardiac Catheterization Laboratory has seen
an increase in the percentage of procedures that have elected the use of the transradial
approach for access for coronary angiography and PCI. In 2008 the radial approach formed
65% of coronary angiographs and PCIs performed in the Catheterization Laboratory. Our
centre has noted a decreasing trend of procedures with failed radial access converting to
femoral access from 12% in 2005 to 4% in 2008, a frequency less than the international
procedural failure rate of 5% which is most likely due to the increased experience of our
operators. There has also been a dramatic increase in the number of left main stem PCI
using the transradial approach from 10% in 2004 to 67% in 2008, which previously was
mostly amenable to CABG surgery. Overall complication rates especially pertaining to
haematomas and vascular injury are less than 1%.
Conclusion: The radial approach now forms a significant route of access for cardiac
catheterization in our centre. Overall complication rates of the centre remain low supporting
the radial approach as the primary access site in PCI even in complex cases involving left
main stem stenosis.

7.

Safety of Deferring Intervention by measuring Fractional Flow Reserve in Coronary
Heart Disease
CL Lau1, PT Tsui1, YK Lo1, NY Chan1, CC Choy1, D. Fong1, D. Chow1, H.C. Yuen1, P.S.
Chu1, N.S. Mok1, S.T. Lau1
1
Department of Medicine and Geriatrics, Princess Margaret Hospital, HKSAR
Objective: Coronary artery stenosis ranges from mild (<50%), moderate (50-70%) to
severe (>70%). Percutaneous coronary intervention (PCI) is usually not required for mild
stenosis, equivocal for moderate lesion and preferably for severe stenosis. Functional
studies performed before PCI can determine whether a coronary artery is causing ischemia
and thus need for PCI. Measuring fractional flow reserve (FFR) is a functional test that can
be done during PCI by a pressure wire. It can identify which artery or specific lesion in an
artery is causing ischemia. Recent studies have shown that PCI guided by FFR reduced long
term mortality or myocardial infarction compared with PCI guided by visual angiographic
assessment.
Method: This was a retrospective case series study conducted in cardiac intervention center
of Princess Margaret Hospital on patients who had FFR measured during PCI. PCI was
deferred in lesion with FFR>0.8.
Results: One hundred twenty-three consecutive patients (21 female, 102 male) of age 61+/10 were recruited. Underlying cardiovascular risk factors were diabetes (27%), hypertension
(46%), hyperlipidemia (58%), current or history of smoking (30%). Prior myocardial
infarction (MI) was present in 43 (35%) patients. Measuring FFR has been unequivocal and
successful in all cases. FFR was measured in 89 lesions in left anterior descending artery
(LAD), 52 lesions in left circumflex artery (LCX) and 37 lesions in right coronary artery
(RCA). Stenting was avoided in 55 (62%) lesions in LAD, 40 (77%) lesions in LCX and 24
(65%) lesions in RCA. After follow-up of 545+/-104 days, none of the PCI deferred patients
had MI. There were six PCI deferred patients readmitted for atypical chest pain. None of them
had MI. One patient received PCI in another hospital and was readmitted again for chest pain
after PCI. There were 4 deaths in the PCI group. Two were sudden cardiac death and the other
two were related to concomitant illnesses. There were also 2 MI in the PCI group.
Conclusion: Measuring FFR in equivocal lesions is practically convenient, cost-effective
and safe by avoiding unnecessary coronary stenting.
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6.

Conventional Coronary Angiogram vs Hybrid Rotational Coronary Angiogram
H. Lam1, K.L. Chui1, Y.H. Chan1, K.C. Ko1, P.W. Yam1, W.K. Lai1, K.F. Tse1, C.S. Lam1, L.
Chow1, M.L. Wong1
1
Tuen Mun Hospital, Hong Kong
Background: CT Coronary Angiogram requires far less radiation, contrast and procedure
time nowadays. How to reduce contrast load and radiation exposure in invasive coronary
angiogram becomes an important issue. A new coronary angiogram protocol – Hybrid
Rotational Coronary Angiogram, which is rotational angiogram on the left coronary arteries
and conventional angiogram on the right, may be the answer.
Methods: This is a retrospective observational study on the safety and efficacy on
conventional coronary angiogram versus rotational coronary angiogram. 200 consecutive
cases undergoing two different coronary angiogram protocols during 09/2010-12/2010
were studied. Differences in contrast usage, procedure time and radiation were analyzed.
Complications, including shock, myocardial infarction, arrthymia, stroke, death and
bleeding, were reviewed.
Results: Hybrid rotational coronary angiogram was associated with 34% reduction in
contrast usage (p <0.0001) and 19.5 % reduction in radiation (p<0.0001). There was no
increase in procedure time (p=ns). Complications were zero in the 100 hybrid rotational
coronary angiogram patients. In conventional angiogram, one ventricular fibrillation was
noted.

Conclusion: Hybrid rotational coronary angiogram is safe and has been shown to reduce
contrast usage and radiation exposure when compared to conventional coronary angiogram.

8.

Medium Term Outcome of Unprotected Left Main Stenting
C.L. Lau1, P.T. Tsui1, Y.K. Lo1, N.Y. Chan1, C.C. Choy1, H.C. Yuen1, P.S. Chu1, N.S. Mok1,
S.T. Lau1
1
Department of Medicine and Geriatrics, Princess Margaret Hospital, HKSAR
Background: Coronary artery disease involving left main is serious and life threatening.
Unprotected left main stenting is an option for patients who refuse coronary artery bypass
surgery and accept higher risk of re-do target vessel revascularization (TVR).
Methods: This was a retrospective case series study conducted in cardiac intervention
center of Princess Margaret Hospital on patients who had undergone unprotected left main
stenting.
Results: Fifty-eight consecutive patients (8 female, 50 male) of age 65+/-9 were recruited.
Underlying cardiovascular risk factors were diabetes (38%), hypertension (60%),
hyperlipidemia (91%), current or history of smoking (55%). Twenty-six (45%) had prior
history of myocardial infarction (MI). Fifty-three (91%) had distal left main bifurcation
lesions and 5 (9%) had ostial or body left main disease. Fifty-seven patients had concurrent
disease in one or more of the three main coronary arteries: 1-vessel (16%), 2-vessel (29%)
and 3-vessel (53%). Only 8 out of 53 distal left main lesions received two stents (5 T-, 1
culotte, 1 crush and 1 kissing stenting). Four patients received bare metal stent in main
branch while the rest had drug-eluting stents. The main branch stent size and length were
3.5+/-0.4mm and 22+/-7mm respectively. The maximum balloon size was 3.8+/-0.4mm
and maximum inflation pressure 16+/-3 atmospheres. High pressure post-dilatation and
kissing balloon inflation was performed in 51 (88%) and 28 (48%) respectively. Fiftysix (97%) had intravascular ultrasonography assessment. This cohort was followed up for
845+/-478 days. Thirteen (22%) patients had major adverse cardiovascular events: 4 target
vessel revascularization, 6 all cause mortality and 1 non-fatal MI.
Conclusion: The medium term clinical outcome of unprotected left main stenting is
comparable to published international data.
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Do Thiazides still have a Place as First-line Agents for Hypertension?
S. SW Chan1
1
Emergency Department, Prince of Wales Hospital, The Chinese University of Hong Kong,
Hong Kong.
Introduction: The UK National Institute for Health and Clinical Excellence (NICE)
2011 guidelines recommend that, for first-line treatment of hypertension, patients under
age 55 years should be prescribed an angiotension converting enzyme inhibitor (ACEI),
while patients above age 55 years should be offered a calcium channel blocker (CCB). In
these guidelines, thiazide-like diuretics had been removed as first-line antihypertensive
drug, compared to the previous version in 2006. However, current European, Australian,
Canadian and American guidelines still include thiazide diuretics in their first-line
recommendations.
Purpose: To answer the question: In adults with hypertension, does the use of thiazide
diuretics compared to placebo, no treatment or other anti-hypertensive medications have
better or worse outcomes?
Methods: A literature search was performed as described below.
Population: adults with hypertension. Intervention: thiazide diuretics. Comparator: placebo or
no treatment, other anti-hypertensive medications
Outcomes: cardiovascular related morbidity and mortality, efficacy in lowering blood
pressure, cost, and adverse effects. Search strategy: using search terms ‘hypertension’ and
‘thiazide’, refined to include only review articles.
Databases used: Medline (OVID), Embase, NICE, NHS Evidence, and Cochrane Database
of Systematic Reviews. Returned articles were screened for relevance and critically appraised
using a checklist from the Centre for Evidence-based Medicine, Oxford University.
Results:Three studies were identified:
1. “Thiazide diuretics as first-line treatment for hypertension: meta-analysis and economic
evaluation” from the Canadian Agency for Drugs and Technologies in Health, 2007. 2.
“First-line drugs for hypertension” from Cochrane Database of Systematic Reviews, 2009.
3. NICE guidelines 2011: Hypertension: clinical management of primary hypertension in
adults (update).
Relevant findings: Compared to placebo or no treatment, thiazide diuretics significantly
reduced the risks of all-cardiovascular events, stroke, cerebrovascular events and
cardiovascular death - results from at least 19 RCTs including 39,713 participants.
Compared to thiazides, ACEIs are associated with higher incidence of strokes (RR 1.13,
95% CI 1.02 to 1.25), and CCBs have a significantly higher incidence of heart failure (RR
1.38, 95% CI 1.25 to 1.53).
Conclusion: Thiazides still have a place as first-line agents for hypertension.

11.

Clinical Application of Peripheral Veno-arterial Extracorporeal Membrane
Oxygenation for Non-Surgical Indications
M.K.L. Wongl, F.C.C. Taml, S.W.C. Sinl, A.S.Y. Yungl, A.Y.T. Wongl, R.H.W. Chanl, S.W.L.
Leel
l
Queen Mary Hospita, Hong Kong
Background: Veno-arterial Extracorporeal Membrane Oxygenation (VA-ECMO)
application in adult population is growing globally as both mechanical circulatory support
(MCS) as well as extra-corporeal cardiopulmonary resuscitation (E-CPR). With the
advance in technique and circuit design, peripheral VA-ECMO can now provide excellent
circulatory support with improved patient outcome. We would like to report the experience
of peripheral VA-ECMO as MCS and E-CPR for patients with non-surgical indications.
Methods: Consecutive recipients of veno-arterial extracorporeal membrane oxygenation
for mechanical circulatory support or extra-corporeal cardiopulmonary resuscitation for
non-surgical indications from October 2010 to December 2011 were included. Patient
characteristics, indications as well as clinical outcome were reviewed. Results: During
the study period, 10 patients received veno-arterial extracorporeal membrane oxygenation
(VA-ECMO) for either mechanical circulatory support or extra-corporeal cardiopulmonary
resuscitation (E-CPR) for non-surgical indications. All of them received peripheral form
of VA-ECMO. The indications for mechanical circulatory support (MCS) include acute
myocarditis (2 patients), thyroid storm (2 patients), dilated cardiomyopathy or right
heart failure (3 patients), ventricular tachycardia storm (1 patient) and extracorporeal
cardiopulmonary resuscitation (E-CPR) (2 patients). Six out of eight patients received VA
ECMO as MCS survived till discharge (75% hospital survival) while all the two patients
received VA-ECMO for E-CPR died despite ECMO support. Overall survival rate is 60%.
During VA-ECMO period, five patients developed critical limb ischemia due to VA-ECMO
arterial cannula which was alleviated after insertion of reperfusion catheter and no limb
amputation is required.
Conclusion: VA-ECMO is an effective circulatory support technique for patients with
non-surgical indications. Peripheral set up of VA ECMO can provide adequate circulatory
support and lower limb ischemic complication can be alleviated with appropriate use of
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10.

Novel Use of Non-invasive Hemodynamic Monitoring Device in a patient with Extracorporeal Circulatory Support
A.Y.T. Wong1, M.K.L. Wong1, R.H.W. Chan1, Y.M. Lam1, S.W.L. Lee1, S.C.C. Lam1, J.S.H.
Hai1, M.P.H. Chan1, F.C.C.Tam1, A.S.Y. Yung1
1
Department of Medicine, Queen Mary Hospital, Hong Kong
A 63-year-old man presented to our hospital for worsening dyspnea. He ran into cardiogenic
shock with BP ~50/30mmHg, and developed VT quickly on arrival. Resuscitation was
done. Inotropes were started. ECG showed sinus tachycardia with LBBB. Bedside
echocardiogram revealed globally impaired left ventricular ejection fraction, with better
contraction in anterior wall. Emergent coronary angiogram revealed thrombotic LCX
occlusion, critical LAD disease with left to right collaterals and distal RCA CTO. Primary
PCI was then proceeded with stenting to LAD and LCX. Venous-arterial Extra-corporeal
Membrane Oxygenation (VA-ECMO) was set up for circulatory support in view of
persistent cardiogenic shock.
Patient gradually recovered over the next few days, with LVEF improved from ~15% to
~30%. We proceeded to weaning of ECMO.
A novel realtime non-invasive hemodynamic monitoring device (Nexfin® from BMEYE)
was used to guide the ECMO weaning process. The device can monitoring stroke
volume, cardiac output and other hemodynamic parameters beat-by-beat. ECMO flow
was deliberately cut down from 1.9L/min to 0.5L/min as a test of the weaning process.
Traditionally many circumferential parameters are measured during this period to assess the
adequacy of end-organ perfusion. In this case, Nexfin® was also employed throughout this
period to observe the change of intrinsic cardiac function before and after the ECMO flow
adjustment. It was noted that during this period the stroke volume increased from 36.76ml ±
2.64ml to 41.18ml ± 2.08ml (p<0.001), while the cardiac output increased from 3.08L/min
± 0.20L/min to 3.51L/min ± 0.19L/min (p=0.027). The heart rate only minimally increased
from 83.9/min ± 1.7 /min to 85.3/min ± 1.4/min (p<0.001). This signified good myocardial
response to decreased extracorporeal support. ECMO was thus successfully weaned off.
We described a case where realtime non-invasive hemodynamic monitoring device can be
used as guidance for the weaning process of an ECMO support system.

12.

The Prognostic Value of Serial NT-proBNP Monitoring in the Management of
Congestive Heart Failure in Chinese
C.H. Lam1
1
Pamela Youde Nethersole Eastern Hospital, Chai Wan, Hong Kong
Background: Heart failure is a major health burden with high rate of readmissions and
mortality. NT-proBNP level has been showed to be a useful prognostic tool of outcome in
the management of patients with heart failure. A large proportion of subjects in previous
international studies include those with impaired left ventricular systolic function. In
our local population, however, the percentage of heart failure patients with preserved
left ventricular ejection fraction (LVEF) is rather high among patients admitted for
decompensated heart failure.
Purpose: This study explores the prognostic role of serial NT-proBNP in the local Chinese
patients with congestive heart failure.
Methods: This was a single centre, prospective study of patients who were admitted to the
acute medical wards of a regional hospital with the clinical diagnosis of congestive heart
failure between October 2009 and August 2010. Serial NT-proBNP concentrations were
measured on hospital discharge and out-patient follow-up. Patients were followed up for
6 months. The primary endpoint was hospital readmission due to heart failure or allcause
mortality at 6 months.
Results: 91 patients were recruited. Echocardiography was performed in 89 patients, 70.8%
of those who had echocardiography performed had a preserved LVEF (LVEF ≥ 50%).
Independent variables associated with readmission were NT-proBNP drop < 40% on followup, haemoglobin level on admission and duration on of heart failure. Creatinine level on
admission was showed to be correlated with 6-month all-cause mortality.
Conclusions: Serial changes of NT-proBNP concentrations are associated with 6-month
readmissions. It can be a useful prognostic marker in the management of heart failure in
local Chinese patients with high prevalence of preserved LVEF.
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14.

Six months clinical outcome for the treatment of in-stent restenosis with newer
generation compared to first generation drug-eluting stents
R.C.Y. Fung1, C.S. Yue1, C.K. Chan1
1
Division of Cardiology, Department of Medicine and Geriatrics, United Christian Hospital,
Hong Kong

Drug-Eluting Balloon In The Treatment of Restenosis After Drug-Eluting Stent
Implantation for Left Main Coronary Artery Disease – a Single Center Experience
Ka-Yip Lo1, Chi-Kin Chan1, Chiu-Sun Yue1
1
Division of Cardiology, Department of Medicine and Geriatrics, United Christian Hospital,
HKSAR

Purpose: The safety and efficacy of first generation drug-eluting stents (DES) in the
treatment of instent restenosis (ISR) has been verified. In this study, patients with bare metal
ISR diagnosed angiographically between 1 Jan 2006 and 31 June 2011 treated with either
first generation (sirolimus or paclitaxel) or newer generation (zotarolimus or everolimus or
biolimus) DES were recruited. Their 6 months clinical outcome was compared.
Method: Patients who had bare metal ISR treated with DES in the United Christian Hospital
between 1 Jan 2006 and 31 June 2011 were included. Those who have mixed generation drug
DES or balloon angioplasty alone were excluded. Demographic data was retrieved from our
clinical records and percutaneous coronary intervention registry. Patients’ baseline parameters
including clinical presentation, age, gender, smoking status, left ventricular ejection fraction,
previous history of cardiovascular disease, previous coronary intervention, comorbidities
including diabetes mellitus, hypertension, hyperlipidaemia, peripheral vascular disease, renal
impairment and medications prescribed were collected. Angiographic data including target
vessel, ISR patterns, total stent length, maximal inflation pressure were compared. Data
regarding their clinical outcomes were retrieved from the computer based clinical record.
Major adverse cardiac events were defined as total mortality, target lesion revascularization
(TVR) and myocardial infarction.
Results: A total of 69 patients were included. Thirty patients were treated with first generation
(paclitaxel and sirolimus) stents and thirty-nine patients were treated with new generation
(everolimus , zotarolimus, biolimus) stents. Baseline characteristics were similar between the
two groups, except for the number of left main (LM) ISR and the maximal inflation pressure
for stent deployment. More LM ISR was treated with the newer generation stents ( 7 vs 1,
P =0.06). And the maximal inflation pressure was significantly higher in the first generation
stents group (17 ± 4.9 mmHg vs. 14 ± 2.0 mmHg, P < 0.05). There was no stent thrombosis
and target lesion revascularization. Three patients had nonfatal myocardial infarctions in
the first generation DES group. One patient died of acute pulmonary oedema and 3 patients
developed non-fatal myocardial infarctions in the newer generation DES group. Cox
regression analysis showed no significant difference in incidence of MACE between patients
treated with newer generation and first generation DES (10.3% vs 10%, RR 1.1, P = 0.92).
Conclusion: In this study, clinical outcome of the treatment of ISR with newer generation
DES was comparable to that of the first generation DES. They may be a promising option for
the treatment of bare metal ISR.

Purpose: The use of percutaneous coronary intervention (PCI) to treat left main coronary
artery (LMCA) disease has been encouraged by the availability of drug-eluting stents
(DES), which significantly reduces the rates of restenosis and repeating revascularization.
However, there is limited data on the treatment of patients with in-stent restenosis (ISR)
after DES treatment for unprotected LMCA disease. Treatment options including bypass
surgery, repeating PCI or medical treatment have not been evaluated in randomized
trial. Thus, the optimal approach is not certain. The aim of this study was to review our
experience in using drug-eluting balloon (DEB) in this unresolved area.
Methods: Between March 2010 and February 2012, five patients (3 men, median age
69, and range 65-80) were treated with DEB for DES-ISR in LMCA disease. Patient’s
clinical characteristics, procedural data, angiographic and clinical outcome were analyzed
retrospectively.
Results: 60% of patients had previous bare-metal stent implantation at left main. All
patients were treated with two-stents strategies by DES for left main bifurcation lesions
(Four by T-stenting and one by Culotte-stenting technique). 60% of patients had ISR of the
side branch only (left circumflex artery) while the others had ISR involving both the main
and side branches. Overall seven DEBs were used with balloon size ranged from 2.5 to
3.5mm, length from 14 to 30mm. In all cases, inflation time of 60 seconds was achieved.
The procedure was successful in all patients. Surveillance angiography three to six months
later showed no significant ISR in all available cases (available in four patients). No major
adverse cardiac events were reported at one-year. However, one patient suffered from
unstable angina and target-vessel revascularization 16 months after DEB treatment.
Conclusion: In selected patients with DES-ISR in LMCA disease, our result with treatment
by DEB was acceptable. DEB may be an acceptable alternative in selected patients.

15.

16.

Plavix Resistance in Hong Kong by VASP (Preliminary report of PR Hong Kong
Study)
H. Lam1, Y.H. Wong1, H.M. Mak1, L.F. Lam1, K.K. Yeung1, Y.H. Chan1, K.C.Ko1, W.F.
Leung1, K.L. Chui1, L.L. Ip1, C.W. Wong1, M.L. Wong1, W.K. Lai1, K.F. Tse1, C.S. Lam1, L.
Chow1, P.W. Yam1, S.F. Yip1
1
Department of Medicine and Geriatrics and Department of Clinical Pathology, Tuen Mun
Hospital
Background: There are two classes of platelet function tests to determine clopidogrel
resistance in patients. The more specific and well accepted one is the vasodilator stimulated
phosphoprotein phosphorylation assay (VASP) by using flow cytometry via signaling
through P2Y12. It has been proven to correlate with clinical events in patients after PCI.
Prevalence of clopidogrel resistance in Hong Kong by using VASP has not been well
studied. It may be different from using point of care system VerifyNow as they assess
platelet function by two different mechanisms.
Objective: The study is to find out prevalence of clopidogrel resistance by VASP in our
local population undergoing elective PCI.
Method: This is a prospective observational study. 60 consecutive patients from 09/201112/2011 undergoing elective PCI in Tuen Mun Hospital are selected for VASP assay by
flow cytometry with written consent. Platelet Reactivity Index (PRI)>50 is used as cutoff
for clopidogrel resistance. All patients are pretreated with clopidogrel 300mg as loading and
75mg as maintenance plus aspirin 160mg. Physicians are blind for test results till the end of
the study.
Results: Platelet Reactivity Index (PRI) varying from 25.3 -95 by VASP assay are recorded
among the 60 patients undergoing elective PCI. 71.7% of patients (n=43) are clopidogrel
non responder with PRI>50. 28.3% of patients (n=17) show PRI>75.
Conclusion: It is alarming that clopidogrel resistance is very high in our population by
VASP assay. If the study result can be confirmed again in other centers in Hong Kong,
we may consider higher dosage of clopidogrel loading or change to newer antiplatelet
treatment.
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Platelet Function Tests Variability Study
H. Lam1, K.K. Yeung1, L.F. Lam1, H.M. Mak1, P.W. Yam1, Y.H. Chan1, K.C.Ko1, W.F. Leung1,
Y.H. Wong1, K.L. Chui1, L.L. Ip1, C.W. Wong1, M.L. Wong1, W.K. Lai1, K.F. Tse1, C.S. Lam1,
L. Chow1, S.F. Yip1
1
Dept of Medicine & Geriatrics & Dept of Clinical Pathology, Tuen Mun Hospital
Background: Antiplatelet treatment failure leads to increase clinical events for patients
undergoing PCI. Checking antiplatelet treatment efficacy before PCI to tailor the drug dosage
becomes more and more popular. However, most of the studies are done with one platelet
function test only. Comparison between different tests to check their consistency has not
been well studied. Recently, a “POPular” Trial has studied different point of care antiplatelet
function tests. It shows that some platelet function tests cannot demonstrate predictive value.
Objective: The study is to test consistency between different platelet function tests from the
most popular point for care VerifyNow, to most well-accepted flow cytometry measurement
of vasodilator-stimulated phosphoprotein phosphorylation (VASP) and the new WBA platelet
function test (Whole Blood Impedance Aggregometry).
Method: This is a prospective observational trial. 31 consecutive patients undergoing elective
PCI in Tuen Mun Hospital from 11/2011 to 12/2011 are selected for 3 different platelet
function tests with written consent after elective PCI. All patients are treated with aspirin
160mg and clopidogrel 300mg loading plus 75mg maintenance. 20 healthy subjects (11 male
and 9 female) were used to set up normal range.
Results: By VerifyNow, patients (n=31) show PRU 81-348. If we take PRU> 230 as cutoff,
54.8 % (n=17) patients are non responder. By VASP, patients (n=31) show PRI 25.5 -83.7. If
we take PRI>50 as cutoff, 37.7% (n=21) patients are non responder. By WBA using collagen
as platelet agonist, patients (n=23) shows 6 minutes impedance 2-19Ω. If we take >10Ω
as cutoff value, 28.6% (n=6) patients are non responder. Comparison between VASP and
VerifyNow (n=31) finds 61.3% (n=19) patients showing consistent result between the two
tests, namely 38.7% inconsistency. Among 21 patients tested by all the 3 tests, only 28.6%
(n=6) patients show consistent results between the tests.
Conclusion: This small study demonstrates the problem of inconsistency between different
platelet function tests results, which may affect the clinical usage and it urges the need for
searching a gold standard in platelet function test in the future, especially after GRAVITAS
Trial. It is alarming to find high prevalence of non responder for antiplatelet treatment in our
local population undergoing PCI.
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Prevalence of Non-responder to Clopidogrel in Patients with Coronary Artery Disease
having Chest Discomfort – Experience from a Local Center
W.W.L Wong1
1
St. Teresa’s hospital, Hong Kong
Purpose: The presence of non-responder to Clopidogrel has been known as a risk factor
for treatment failure and serious complication like stent thrombosis. However, there is no
reliable clinical parameter that can predict which patient would be a non-responder. This
observational study would like to find out the prevalence of non-responder in a group of
patient with coronary artery disease on Clopidogrel
Methods: Patients with coronary artery disease on Clopidogrel who had experienced any
chest discomfort in the absence of clinical evidence of ischemia during follow up would
be advised to have a blood test for P2Y12 inhibition. The clinical records of these patients
who actually had the test done were reviewed at the end of the study period. According to
the local laboratory, patients on a stable dose of Clopidogrel with an inhibition level less
than 30% were defined as nonresponder. Results: The number of patient recruited were
49 from year 2010 till 2011.The male to female ratio were 5. 92% were Chinese. There
were only 53% of patients being a responder with a level of inhibition of greater than 30%.
Average level of P2Y12 inhibition was only 10% among non-responders (ranged from 0 –
28%) and 53% among responders (ranged from 31 – 76%). 17 of the non-responders were
switched to Prasugrel. 10 of them have repeated blood test for the P2Y12 inhibition level,
all showing an adequate level of inhibition with an average of 59% (ranged from 38 –
94%). 8% of patients reported easy bruising and epistaxis while on Clopidogrel.
Conclusion: Patients with coronary artery disease needed anti-platelet treatment may
not have adequate response when they are non-responder to Clopidogrel. The prevalence
could be higher than expected as was in the cohort of patients in this study. Patient as nonresponder can be clinically silent or just with minimal symptom. More studies would be
needed to see if routine surveillance for nonresponder is cost-effective among patients with
coronary artery disease who need
Clopidogrel treatment.
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Postoperative Pain and Impact of Analgesics on Arterial Reactivity in Postmenopausal
Women After Non-cardiovascular Surgery
Wu Meng Jun1, Chook Ping3, Wei An Ning2, Hu Yan Jun2, Woo Kam Sang3
1
The Chengdu Women and Children Affiliated Hospital, 2 The Second Affiliated Hospital,
Chongqing University of Medical Sciences, 3The Chinese University of Hong Kong
Introduction : Cardiovascular (CV) events may complicate abdominal surgery in
postmenopausal women, probably related to operative trauma and postoperative pain.
Arterial reactivity (endothelium-dependant flow-mediated dilation, FMD) is an emerging
novel atherosclerosis surrogate marker predictive of CV events.
Objectives: To evaluate the relationship between postoperative pain and impact of
analgesic on FMD in postmenopausal women after abdominal surgery.
Patients & Methods: We enroled 60 postmenopausal women, aged 60-80 years (mean
56.1+10.6 year) undergoing laparoscopic abdominal surgery. 30 patients were given
continuous intravenous analgesics infusion (fentanyl and droperidol) (Analgesic Group),
and 30 patients were treated with intramuscular dolantin 1-2 times on demand for first 24
hours (Control Group). Pain was assessed by visual analogue score (VAS).
Results: The 2 groups were compromable in their mean age, nature of surgeries, basal VAS
and brachial FMD. VAS were increased and brachial FMD reduced at 2 hours postoperative
compared with preoperative day-1 in both groups (p<0.05). Compared with Control Group,
Analgesic Group had lower VAS and higher brachial FMD at postoperative 2 hours and
day-1, and better preserved brachial FMD at day-5.

Preoperative: day-1
Postoperative: 2 hrs
day-1
day-5

CONTROL GROUP
VAS
FMD(%)
0.8+1.3
7.1+1.6
4.8+2.8
5.7+1.3
3.1+1.4
5.9+0.9
1.1+1.3
6.3+1.6

ANALGESIC GROUP
VAS
FMD(%)
0.6+1.1
7.3+1.4
2.7+1.9**
6.5+1.3a
1.7+1.2*
7.2+1.3a
0.9+1.0
7.3+1.3b

18.

Role of TRPC3 Channel in Human Internal Mammary Artery
Gao Ge1, Xiao-Yan Bai1, Chao Xuan1, Xiao-Cheng Liu1, Wen-Bin Jing1, Qin Yang1, 2, and
Guo-Wei He1, 3
1
TEDA International Cardiovascular Hospital, Medical College, Nankai University,
Tianjin, China; 2The Chinese University of Hong Kong, Hong Kong, China; 3Department
of Surgery, Oregon Health and Science University, Portland, Oregon, U.S.A.
Purpose: Intracellular calcium regulation in endothelial cells depends on transient receptor
potential channels (TRPs). Canonical TRPs (TRPCs) are now recognized as the most
important Ca2+-permeable cation channels in vascular endothelium and TRPC3 channel is
reported to play a role in vasodilation in animal vessels. However, little is known about the
role of TRPCs in the human arteries. We therefore tested the hypothesis that TRPCs plays a
role in the human arteries.
Methods: Cumulative concentration-relaxation curves to acetylcholine (–11 to –4.5 log M)
were established in the human internal mammary artery (IMA) rings (n=36) taken from 21
patients undergoing coronary artery bypass grafting in pre-contraction induced by U46619
(–8 log M) in the absence or presence of SKF96365 (10 μmol/L) or Pyr3 (3 μmol/L).
Protein expressions of TRPC3 were determined by Western Blot.
Results: The maximal relaxation induced by acetylcholine was significantly attenuated
by the non-speciﬁc inhibitor of TRPCs, SKF96365 (45.9±3.9% vs. 63.5±1.4% in control,
P<0.05) or the selective TRPC3 blocker, Pyr (56.1±4.2% vs. 65.7±2.7% in control,
P<0.05). The protein expression of TRPC3 was detected in human IMA.
Conclusion: TRPC3 exists and plays a role in the acetylcholine-induced endotheliumdependent relaxation in the human IMA. This study suggests that TRPC3 may have
the potential to be a new target in endothelial protection in patients with endothelial
dysfunction such as in patients with coronary artery disease in order to improve the long
term patency of the grafting vessels.

			Compared with Control *p<0.03; **p<0.04; a:
p=0.001; b: p=0.015
Of the 60 women, VAS>5 were independently associated with better brachial FMD (>6%)
at postoperative 2 hours (OR=1.9, 95% CI 0.7 to 5.1, p<0.02).
Conclusion: Postoperative pain is inversely related to vascular reactivity in postmenopausal
women, which is potentially ameliorated by upfront analgesic administration after
abdominal surgery.

19.

20.

Aortic Root Replacement Surgery – Approaching Zero Hospital Mortality
C.K.L. Ho1, L.C. Cheng1, T.W.K. Au1
1
Department of Cardiothoracic Surgery, Queen Mary Hospital, Hong Kong
Purpose: Retrospective analysis of consecutive aortic root replacement surgery in a single
institution.
Methods: From January 2001 to November 2010, 93 patients underwent 94 aortic root
replacement and 2 aortic root repair surgery. Aetiology included Marfan syndrome 42%,
annulo-aortic ectasia 31%, non-Marfan aortic dissection 18% and aortitis 9%. Twenty-seven
percent were emergency and 29% were reoperation.
Results: Bentall operation was performed in 87 patients, 7 had valve-sparing aortic root
replacement and 2 had aortic root pseudoaneurysm repair after previous Bentall operation.
Concomitant surgery included arch replacement in 9 patients, CABG [6 ], mitral [6 ], other
cardiac surgery [3]. Deep hypothermia circulatory arrested were performed in 33 patients.
There was only one in-hospital mortality [surgeon’s factor]. Post-operative complications
included bleeding required reopen 8%, wound infection 4%, minor stroke 3%, renal dialysis
2%, permenant pacemaker 2%, redo root surgery 1%. Follow up was 100%. There were 9
late deaths : 5 were Marfan syndrome with further dissection or progressive heart failure,
1 had cerebral hemorrhage, 1 had kidney cancer and dissection and 2 were unknown. Five
years and 10 years actuarial survival were 83% and 79% respectively.
Conclusion: Aortic root replacement either by Bentall or valve-sparing technique is safe
with low morbidity and approaching zero hospital mortality even in high risk patients.
Surgeon’s factor did affect the outcome.
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Pericardectomy for Constrictive Pericarditis in Modern Hong Kong: Results and
Predictors of Outcome
B.A. Rocha1, T.L. Chan1, K.L. Ho1, F. Tsang1, W.K. Au1
1
Department of Cardiothoracic Surgery, Queen Mary Hospital, Hong Kong
Purpose: To assess the current demographics and outcome of patients referred for
pericardectomy, and to identify risk factors for poor clinical outcome.
Methods: Retrospective review of all consecutive patients who had undergone
pericardectomy for constrictive pericarditis from 1995-2011, from hospital data at Queen
Mary Hospital & Grantham Hospital, Clinical Management System, and thru telephone
interviews.
Results: 43 consecutive patients had pericardectomy during the studied period, with 13
females and 30 males. The mean follow-up time was 75 months. 49% were idiopathic,
34.9% were tuberculosis related and 9.3% were related to previous cardiac surgery. The
most common presenting symptom was congestive heart failure (65%), followed by ascites
(14%), pleural effusion (9.3%), and arrhythmias( 7%).
All pericardectomies were performed via sternotomies, with 23% (10/42) requiring
cardiopulmonary bypass. 16.3% (7/43) had concomitant procedures. The operative
mortality was 11.6% (5/43), with 4/5 dying from post-op low output syndrome. The 10year actuarial survival rate was 74%. When using operative mortality, event free survival
and good symptomatic control (NYHA I) as outcome measures, the statistically significant
common unfavorable factors were old age, poor pre-op NYHA class, need for concomitant
procedures, poor pre-op renal function, and less extensive proportion of pericardectomy.
Contrary to our previous belief, a prolonged period between diagnosis of constrictive
pericarditis and pericardectomy does not cause worse clinical outcome.
Conclusion: Pericardectomy remains a high risk operation with good functional outcomes
in late surviors. Tuebrculosis remains a major cause of constrictive pericarditis in this
locality. Advance age, poor NYHA grades, need for concomitant procedures, poor
preoperative renal function, and a less extensive pericardectomy are factors for poor
clinical outcome.
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Cardiac Genetic Service in Management of Inherited Arrhythmogenic Diseases –
Pioneering Experience of a Regional Referral Centre
NS Mok1, WT Poon2, Chloe Mak2, PT Tsui1, NC Fong3, KC Lee2, ST Lau1, KC Tse3, CW
Lam4, Albert Chan2
1
Dept of Medicine & Geriatrics, PMH
2
Dept. of Pathology, PMH
3
Dept of Paediatrics & Adol Medicine, PMH
4
Dept of Pathology, HKU
Purpose: Hong Kong is lagging behind her Asian counterparts in provision of cardiac
genetic service which plays an important role in management of inherited arrhythmogenic
diseases (IAD). Princess Margaret Hospital (PMH) is a regional referral centre for IAD and
PMH genetic laboratory embarked on cardiac genetic service for management of IAD in
2007. We reported the results of molecular diagnosis and clinical profile of IAD in a cohort
of local patients and their family members.
Methods: Clinical and genetic data of probands and their family members with a molecular
diagnosis of IAD who received treatment and/or underwent genetic testing in PMH were
reviewed and analysed.
Results: A total of 23 probands (M:F 17:6, mean age 36.8±24.5 years) had molecular
diagnosis of IAD. Fifteen were confirmed by genetic laboratory in PMH and eight by
other laboratories. All but one (96%) probands are Chinese. The molecular diagnosis was
Brugada syndrome (BrS) with SCN5A mutations in seven; congenital long QT syndrome
(LQTS) in six (LQT1 with KCNQ1 mutations in three, LQT2 with KCNH2 mutations
in two and JLN2 with KCNE1 mutation in one); catecholaminergic polymorphic VT
(CPVT) with RyR2 mutations in two; hypertrophic cardiomyopathy (HCM) in six (MYH7
mutations in three and MYBPC3 mutations in three) and arrhythmogenic right ventricular
cardiomyopathy (ARVC) with PKP2 mutations in two. Two probands had history of
cardiac arrest, ten had syncope and nine had documented VT/VF. Six received ICD, one
received pacemaker while 12 were on medical treatment. Thirty nine family members of
13 genotyped probands were screened for the known pathogenic mutations. Among them
18 were found to be mutation carriers (ARVC in six, HCM in two, LQTS in seven and
BrS in three) and appropriate treatment and advice on lifestyle modifications were given
accordingly. Family members with negative mutation were reassured without further
investigation or long-term follow-up.
Conclusion: Genetic testing for IAD is feasible in Hong Kong and should be considered
for diagnosis, risk stratification, guiding treatment and genetic counseling of patients and
for family screening of known pathogenic mutations in IAD.

23.

Nonfluoroscopic Intracardiac Navigation System Guiding Cardiac Electrophysiologic
Procedures – Pilot Experience in PMH
C.L. Lau1, N.S. Mok1, Y.K. Lo1, P.S. Chu1, H.C. Yuen1, C.C. Choy1, H.F. Chow1, N.Y.
Chan1, P.T. Tsui1, S.T. Lau1
1
Cardiac Team, Princess Margaret Hospital, Hong Kong
Purpose: Fluoroscopy is required for positioning of diagnostic and mapping
electrophysiologic catheters and guiding catheters in cardiac electrophysiologic
procedures (CEP) which carries radiation hazards to both patients and doctors. Use of a
non-fluoroscopic intracardiac navigation system (NINS) has been shown to reduce the
fluoroscopy time in CEP. This abstract reported our initial experience in using NINS in
guiding CEP.
Method: Fourteen consecutive patients who underwent CEP guided by NINS were
included. The nature of arrhythmias was reviewed. Fluoroscopy time used in positioning of
diagnostic and mapping electrophysiologic catheters and ablation of arrhythmias, as well as
total procedural time were analysed.
Results: Three patients had no inducible arrhythmia. 11 patients had inducible arrhythmias
with catheter ablation of the arrhythmogenic substrate done. Among them seven had
WPW syndrome with inducible orthodromic AVRT, two had typical atrial flutter, one had
AVNRT and one had dual mechanisms (AVRT and AVNRT). Catheter ablation (RF ablation
in eight, cryoablation in two and both RF and cryoablation in one) was successful in all
eleven patients without vascular or intracardiac complication. Positioning of the diagnostic
electrophysiologic catheters was done without fluoroscopy in all but one patient who had
atrial flutter with difficult right ventricular entry. In two patients, one with atrial flutter and
the other with AVNRT, successful ablation was performed without any fluoroscopy. The
mean (±SD) fluoroscopy time in catheter ablation and procedural time were 22±17 minutes
and 151±60 minutes respectively.
Conclusion: Our initial experience showed that the use of NINS in guiding CEP is feasible
and safe and has a potential to reduce fluoroscopy time and radiation hazards in CEP.
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51.

To Observe the Short Term Therapeutic Effect of Intravenous Injection and Take
Orally of Herbesser Sequentially on fast Atria Fibrillation
X.X. Liao1, C.L. Hu1, X. Li1, R. Liu1, H.Y. Wei1
1
The Department of Emergency of the First Affiliated Hospital, Sun Yat-sen University,
People’s Republic of China
Objective: To explore the short term therapeutic effect of intravenous injection and take
orally of Herbesser sequentially on fast atria fibrillation.
Methods: 106 patients with fast atria fibrillation origin from different cardiac diseases were
enrolled and randomly divided into Control group and Observation group. The patients in
Control group were treated by intravenous injection cedilanid and oral digoxin, the other
patients in Observation group were treated by intravenous injection and take orally of
Herbesser sequentially. To observe and compare the effects of different therapy methods
in controlling the ventricular rate during the hospital stay and within 4 weeks after hospital
discharge.
Results: There were 53 patients in each group, the ratio of gender and age were no
difference between two groups. The effective power were 98.1% in Herbesser group, higher
than 77.2% in intravenous injection cedilanid and oral digoxin group, P=0.002. The rates
of ventricular attain the target were 84.9%, 81.1%, 79.2% and 77.4% in Herbesser group
within 4 weeks after hospital discharge higher than 66%, 55.6%, 55.6% and 47.2% in
cedilanid and oral digoxin group(P= 0.041, 0.011, 0.021 and 0.002 respectively).
Conclusions: The methods of intravenous injection and take orally of Herbesser
sequentially can effetely control the ventricular rate of fast atrial fibrillation, and the effect
was super the combination of cedilanid and oral digoxin.
Keywords: Herbesser; cedilanid digoxin; fast atrial fibrillation

24.

Reduction of fluoroscopy exposure in catheter ablation of atrioventricular nodal reentrant tachycardia and accessory pathway using the three-dimensional mapping
system: initial experience in Hong Kong
M.C. Choi1, K.T. Lee1, H.L. Chan1, C.H. Chau1, K.L. Wu1, S.H. Cheung1, C.Y. Cheung1, K.L.
Tsui1, K.K. Chan1, S.K. Li1
1
Department of Medicine, Pamela Youde Nethersole Eastern Hospital, Hong Kong
Purpose: Catheter ablation procedures carry radiation risk to patients and clinicians.
Recent studies demonstrated that the use of 3D mapping systems reduced fluoroscopy time
during ablation procedures of atrial arrhythmias. The purpose of our study was to assess the
feasibility and safety of catheter ablation of atrioventricular nodal re-entrant tachycardia
(AVNRT) and accessory pathway (AP) using the 3D mapping system.
Methods: From April 2011 to Feb 2012, we prospectively enrolled the patients with
AVNRT or AP treated by catheter ablation guided by EnSite NavX system (Group A).
These patients were compared with a matched control group of patients (Group B). We
compared the success and complication rates, procedure and fluoroscopy time and number
of ablations.
Results: 15 patients were enrolled in each group (8 AVNRT cases and 7 AP cases).
Zero fluoroscopy was needed during electrophysiology study in all patients of group
A. In 11/15 cases (73%) of group A, 3D mapping avoided fluoroscopy entirely during
ablation procedure, including 4 cases requiring access to the left ventricles by a retrograde
approach. The mean total fluoroscopy time was 6.5±13.2s in group A and 22.3±19.1s in
group B (p<0.05). There was no significant difference in procedure times and number of
ablation between two groups. All ablation procedures were successful without any major
complication in both groups.
Conclusion: Catheter ablation of atrioventricular nodal re-entrant tachycardia and accessory
pathway using the 3D mapping system is safe and feasible. It is associated with significantly
reduction in fluoroscopy time, without increase in procedure time. This approach deserves
consideration, particularly in patients at high radiation risk.
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Prospective Cohort Study of Catheter Ablation of Persistent Atrial Fibrillation in a
Single Centre
Y.K. Ko1, J.Y.S. Chan1, C.P. Chan1, H.C.K. Chan1, J.W.H. Fung1, C.M.Yu1
1
Division of Cardiology, Department of Medicine and Therapeutics, Prince of Wales
Hospital, The Chinese University of Hong Kong.
Purpose: Catheter ablation for patients with drug-refractory symptomatic atrial fibrillation
(AF) has become the recommended treatment in guidelines. The ablation procedure for
persistent AF is technically more challenging with lower long term success rate compared
with the procedure for paroxysmal AF. The purpose of this study was to access the long
term success rate of radiofrequency catheter ablation for patients with persistent AF.
Methods: 39 consecutive patients (age 53.8 ± 12.2, 89.7% male, LA diameter 4.7 ± 0.8cm,
LVEF 0.54 ± 0.15) with drug refractory persistent AF were studied. Ablation procedure was
performed with 3D mapping system (Either Ensite or Carto system) and irrigated ablation
catheter. After achieving pulmonary vein isolation, additional ablation targeting complex
fractionated atrial electrogram (CFAE) and linear ablation were performed (including roof,
mitral isthmus and cavotricuspid isthmus lines). Clinical recurrence of AF was defined
as AF or atrial tachycardia (AT) (including atrial flutter) lasted more than one minute in
duration.
Results: The mean duration of AF was 53.2 ± 47.7 months before the ablation procedure.
During the ablation procedure, in 10 patients (25.6%) AF was terminated (5 patients (12.8%)
converted to AT, and 5 patients (12.8%) converted directly to sinus rhythm), and in 29
patients (74.4%) AF did not organize or terminate and was cardioverted. Duration the follow
up time of 18 ± 11 months, 23 patients (59.0%) remained free from AF. 9 patients (23.1%)
required more than one ablation procedure. 21 patients (53.8%) were taking anti-arrhythmic
agents after the procedure. There is no statistical difference between group achieving AF
termination and the non-termination group the in terms of long term maintenance of sinus
rhythm (P = 0.13)
Conclusions: Among patients with drug-refractory, symptomatic persistent AF, about 60%
of them become AF-free after radiofrequency catheter ablation. And AF terminates or not
during ablation procedure may not affect long term success in maintaining sinus rhythm.
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49.

Premature Ventricular Ectopic and Tachycardia Ablation from Right Ventricular
Outflow Tract and Non Right Ventricular Outflow Tract sites
L.L. Cheung, C.P. Chan, Y.S. Chan, Y.K. Ko, W.H. Fung, C.K. Chan, C.M. Yu
Background: Frequent isolated premature ventricular complexes (PVCs) can led to
serious symptoms and left ventricular dysfunction even in patients without structural heart
disease. Catheter ablation of PVCs, particularly if it originates from the right ventricular
outflow tract (RVOT), has been achieved a cure rate of 90%. In this study, the comparison
was made on the clinical outcome of patients underwent catheter ablation of PVCs from
different origins.
Method: From February 2009 to March 2012, 37 consecutive patients (54% females)
presenting with symptomatic frequent ventricular ectopics, were investigated
electrophysiologically. The age range from 24 to 84, with a mean of 52.9 years. The mean
Left ventricular ejection fraction was 57.4%. 20 patients (54%) had PVC arising from
RVOT sites. 17 patients (46%) had PVC arising from non RVOT sites. Of these, Five
(29%) were from anterior mitral annulus, three (8%) were from RV septum. 2 (5%) were
from LVOT sites, 2 were from tricuspid valve, the rest were from RV papillary muscle, LV
papillary muscle, left coronary cusp, right coronary cusp and one from mid posterolateral
LV wall. Among those 20 patients with PVCs arising from RVOT, 14 patients (70%) were
female, two patients (10%) had history of ventricular tachycardia. The mean age was 53+/14 years. The mean LVEF were 61.7+/-7.6%. The mean duration of symptoms presented
were 3.64+/-3years. In 17 patients with PVCs arising from non-RVOT site, 6 patients
(37%) were female, 5 patients (29%) had history of ventricular tachycardia. The mean age
was 52.5+/-18.3 years. The mean LVEF were 51+/-12%. The mean duration of symptoms
presented was 4.87+/-6.8 years.
Ablation was acutely successful in 19 patients (95%) with RVOT PVCs. None of them had
complications. The acute successful rate was 100% in 17 patients of non-RVOT PVCs.
Among them, one patient (1.5%) experienced transient complete heart block and recovered
during the hospital stay. However, no death occurred acutely and two years after catheter
ablation. During a follow up period of two years, 3 patients with non-RVOT PVCs (18%)
had symptoms recurred and 1 patient with RVOT PVCs (5%) had symptoms recurred.
Conclusions: The results of this prospective study demonstrate a high acute success rate
and a clinically negligible complication rate of catheter ablation of symptomatic frequent
PVC regardless of the site of PVC origin. Catheter ablation for PVC arising from RVOT
has a high success rate and relatively lower recurrence rate and should be considered as a
non-pharmacological curative treatment for symptomatic patients.
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Mid-term Results of Concomitant Modified Maze Procedure for Chronic Atrial
Fibrillation in Patients Undergoing Cardiac Surgery – A Chinese Prospective
P.M.F. Lin1, W.K. Au1, T.L. Chan1
1
Division of Cardiothoracic Surgery, Department of Surgery, University of Hong Kong,
Queen Mary Hospital, Hong Kong

27.

Surgery for Late Rheumatic Tricuspid Regurgitation with Previous Left Heart Valve
Surgery – Repair vs. Replacement
T.T.H. Ling1, L.C. Cheng1, C.K.L. Ho1, T.W.K. Au1
1
Department of Cardiothoracic Surgery, Queen Mary Hospital, Hong Kong

Purposes: Concurrent atrial ablation is now a common and standard procedure during
cardiac surgery to treat atria; fibrillation. Success rate varies according to different disease
population, techniques and definition. Although commonly performed, data and results on
Chinese population are lacking. This study is to review the mid-term results of patients had
undergone cardiac surgery and concomitant atrial ablation.
Methods: From 2005 to 2009, 122 consecutive patients with chronic atrial fibrillation
associated with other cardiac problem had undergone modified maze III procedure as
concomitant surgical ablation. Clinical and operative data was reviewed. Patients were
followed up at 3 months and then every 6 months with ECG and clinical assessment.
ults: All patients suffered from chronic atrial fibrillation before operation, ranging from
1 to 220 months. Most patients associated with valvular surgery (93.4%), especially
involving mitral valve (88.6%). There was 1 (0.8%) in-hospital death and 3 (2.4%) follow
up mortality in this cohort. Mean follow up time was 36.7 months (ranging from 12 to 66).
There were significant symptomatic improvement after surgery (p<0.001), whether or not
the rhythm successfully converted. The success rate increases from 63.6% at 3 months to
76.9% at 12 months. Some patients reverted back to atrial fibrillation, making overall rate
of conversion at last follow up was 68.9%. The gain in success rate was contributed by trial
of cardioversion, in which 24 patients (66.7%) became sinus afterwards. Longer duration
of atrial fibrillation and larger the left atrium were poor prognostic factors for successful
ablation.
Conclusion: Concomitant modified maze procedure is a safe and effective technique to
treat chronic atrial fibrillation. Mid-term results in Chinese patients were satisfactory and
comparable to other cohorts.

Purpose: The aim of this study was to compare the hospital mortality and mid-term
outcome undergoing tricuspid replacement versus repair surgery for late significant
rheumatic tricuspid regurgitation who had previous left heart valve(s) surgery.
Methods: Retrospective review of our data between January 2000 and August 2009.
Out of 497 patients underwent tricuspid valve surgery in our institution, 173 patients
had rheumatic disease with previous valves surgery performed. Fifty seven patients had
tricuspid replacement [100% bioprothesis]. In the repair group, 41 patients had simple De
Vega annuloplasty and 75 patients had annuloplasty band. EuroSCORES of the tricuspid
replacement group and repair group were 7.6 and 7.9 respectively. Twenty-one percent of
the replacement group had previous tricuspid valve surgery compared to only 9% in the
repair group [p=0.024]. Concomitant procedures included mitral [56%], aortic [44%] and
CABG [4%]. Follow up was 96% complete with mean 3.8 ± 2.4 years.
Results: The in-hospital mortality [16 death] was 11% for the replacement group compared
to 9% for the repair group [p=0.75]. Univariate analysis showed male sex, LVEF<30%,
cardiogenic shock, active endocarditis, ventilation pre-op, pulmonary hypertension,
creatinine>200 mmol/L and emergency were significant risk factors. Multivariate analysis
revealed cardiogenic shock was the only significant factor [p=0.002 and Exp(B)=42.5] for
in-hospital mortality. Post-operative complications were seen in 42% of the replacement
group compared to 62% in the repair group. Late death occurred in 26 patients. The
actuarial survival were 52% and 60% respectively for the replacement and the repair group
at 8 years [Log-rank p=0.39].
Conclusion: Surgery for late rheumatic tricuspid regurgitation carried considerable
morbidity as well as mortality. However, tricuspid replacement had similar in-hospital
mortality compared to tricuspid repair. Medium term outcome also did not showed
significant difference between the 2 groups.

28.

29.

Minimally Invasive versus Conventional Sternotomy for Cardiac Surgery
O. Lee1, W.k. Au1
1
Division of Cardiothoracic Surgery, Department of Surgery, University of Hong Kong,
Queen Mary Hospital, Hong Kong

Surgical repair of Post-infarction Ventricular Septal Defect: Factors affecting Longterm Survival
N. Yam1, W.K. Au1
1
Division of Cardiothoracic Surgery, Department of Surgery, University of Hong Kong,
Queen Mary Hospital, Hong Kong

Background/purpose: The aim of this study is to compare minimally invasive cardiac
operations with conventional cardiac operations in terms of post-operative pain, length
of hospital stay, post-operative bleeding, post-operative infection, intra-operative
cardiopulmonary bypass time, pre-discharge echocardiogram and 30 day mortality.
Methods: From Jan 2007 to Dec 2011, 71 patients who underwent open heart surgery
were included in this study; 40 patients (56.3%) underwent mini-thoracotomy, 31 patients
(43.7%)underwent median sternotomy. From the total of 71 patients, 19 were ASD repairs
(26.8%), 30 MV repairs (42.3%), 10 MVRs (14.1%), 9 AVRs (12.7%), 2 DVRs (2.8%), 1
Myxoma excision (1.4%). Post-operative pain was assessed using the visual analogue pain
scale given to patients on post operation day 4 or 5, and on the day of discharge. Length of
hospital stay, ICU stay, post-operative bleeding and infection, and 30 day mortality were
documented and analyzed.
Results: Patients with mini-thoracotomy had lower pain levels both on day 4 or 5 and on
discharge. The mean pain score on day 4 or 5 was 2.3 and 3.9 (p<0.05) respectively for
mini-thoracotomy and median sternotomy. The mean pain score on discharge was 1.4 and
2.4 (p<0.05). The mini-thoracotomy group also tended to have a shorter ICU stay postoperatively. There were no significant differences between the 2 groups in hospital stay,
bypass time, wound infection, post-operative bleeding, pre-discharge echocardiogram and
30 day mortality.
Conclusions: Minimally invasive cardiac surgery appear to have no significant difference
to conventional cardiac surgery in terms of quality of surgery, post-operative complications
and mortality; while offering advantages of lower post-operative pain and shorter ICU stay.
As the trend of increasing minimally invasive cardiac surgery continues, we look forward
to further studies with larger population sizes showing advantages of minimally invasive
cardiac surgery in further areas.

Purpose: Post-infarction ventricular septal defects require surgical repair to close the
acute left-to-right shunt for patient salvage but long-term survival after surgery is not well
established. The study was designed to investigate the current outcomes after surgery and
determinants affecting long-term survival.
Methods: Between January 1995 to January 2012, 42 post-infarction ventricular septal
defects were operated on at our division in Queen Mary Hospital (formerly in The
Gratham Hospital) in 40 patients (16 males, 24 females) of ages 56 to 80 years (median 69
years). Long-term follow-up in all survived patients were investigated by univariate and
multivariate analyses (Follow-up duration, mean+/- standard deviation, 5.2 +/- 5.3 years,
longest follow-up 16.8 years).
Results: 30-days mortality for post-infarction ventricular septal defects in our cardiac
surgery centre is 20% (n = 8). Overall survival at 1 year, 5 years and 10 years were 68%,
55% and 42% respectively. Event-free survival from subsequent angina, myocardial
infarction, congestive heart failure or percutaneous interventions at 1 years, 5 years and 10
years were 66%, 43% and 25% respectively. Surgery on later half of the study period has
higher survival (41.6% versus 59.2%). Operations performed immediately after transferral
(i.e. emergency) has similar outcome to those performed in urgent basis (next morning
operating list). Operations performed semi-urgently after medical optimization carries best
results. Performing concomitant coronary artery bypass graft surgery has no additional
advantage over repair of post-infarction ventricular septal defects alone in terms of overall
and cardiac-event free survival.
Conclusion: Surgical repair of post-infarction ventricular septal defects has satisfactory
results. Repair of ventricular septal defects alone with /without concomitant coronary
bypass grafting did not influence long-term outcome
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A Novel Variation of PLAGL1 in Chinese Population with Isolated Ventricular Septal
Defect
Xiao-Yan Bai1, Chao Xuan1,, Bin-Bin Wang2, Ge Gao1, Qin Yang1, 3, Xiao-Cheng Liu1,Xu
Ma 2 & Guo-Wei He1, 4
1
TEDA International Cardiovascular Hospital, Medical College, Nankai University, Tianjin,
PR China
2
National Research Institute for Family Planning, Beijing, PR China
3
The Chinese University of Hong Kong, Hong Kong, PR China; 4Department of Surgery,
Oregon Health and Science University, Portland, Oregon, U.S.A.
Purpose: Ventricular septal defect is the most common congenital heart disease. A number
of genetic studies have linked the gene of PLAGL1 to the etiology of congenital heart
disease. The present study aimed to identify potential pathogenic mutations for PLAGL1
and to provide insights into the etiology of isolated ventricular septal defect.
Methods: Case-control mutational analysis was performed in 300 patients with isolated
ventricular septal defect and 300 healthy controls. Two protein-coding extons of PLAGL1
and their partial flanking intron sequences were amplified by polymerase chain reaction and
sequenced on an ABI3730 Automated Sequencer. CLC workbench software was used to
compare the conservatism of PLAGL1 protein with other multiple species.
Results: Neither missense nor frame-shift mutations were detected in two protein-coding
extons of PLAGL1. But a novel synonymous variation (c. A486G, p. E162E) was detected
in protein-coding exon 2. The glutamic acid which translated with the mutational codon is
conservative when compared with other species.
Conclusions: We detected a synonymous variation in the protein-coding exon 2 of
PLAGL1 in isolated ventricular septal defect patients. It is possible that the etiology of
isolated ventricular septal defect might not be directly linked with this mutation, but might
associated with other patterns of gene expression regulation in PLAGL1, such as in the
methylation-dependent manner.
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Transcatheter Aortic Valve Implantation (TAVI) – Initial Experience in Hong Kong &
Intermediate-term follow-up
Michael KY Lee1, LK Chan1, KC Chan1, CY Wong1, KT Chan1, CB Lam1, C Leung1, MC
Chan1,MY Fan1, KW Leung1, HL Cheung2, CC Ma2, E So3, D Fok3, YF Chow3, MK Chan4, W
Chan4, S Chan4, SF Yip4, A Cheung4, CS Chiang1
1
Deptof Medicine 2Dept of Cardiothoracic Surgery 3Dept of Anaesthesiology 4Dept of Radiology
& Imaging, Queen Elizabeth Hospital
Introduction: In the ageing population, aortic stenosis (AS) is the most common valvular heart
disease, with a prevalence of 4.6% in adults ³75 years of age. When patients with severe AS
presented with the triad symptoms of congestive heart failure, syncope or chest pain, the average
survival is only 2-3 years with high risk of sudden death. Surgical aortic valve replacement (SAVR)
is the standard treatment but many symptomatic AS patients do not receive SAVR because of
underlying co-morbidities or deemed inoperable by the surgeons. Transcatheter Aortic Valve
Implantation (TAVI) has recently provided another treatment option for these patients.
Methods: A TAVI team comprising cardiologists, cardiac surgeons, anaesthesiologists, cardiac
radiologists and cardiac nurses, was formed in early 2010 in Queen Elizabeth Hospital. All
potential patients would be interviewed independently by the cardiologists and cardiac surgeons.
The Heart Team then decided whether the patient was too high-risk to undergo SAVR and suitable
for TAVI. All patients were assessed by echocardiogram, TEE, CT scan and angiogram to decide
on suitability. Echocardiogram and 6-minute walk test would be performed according to protocol.
All complications would be reported to an independent Safety Monitoring Committee.
Results: From December 2010 to February 2012, 13 patients (7 males and 6 females) with
symptomatic severe aortic stenosis underwent the TAVI procedure. Average age 80.6±2.8 years.
All procedures were done under general anaesthesia in our cardiac catheterization laboratory. All
patients had their femoral arteries closed with Prostar or Proglide except the subclavian approach
patient. Aortic valve area improved from 0.73±0.19cm 2 to 1.97±0.26cm2 and mean gradient
decreased from 53.9±12.3mmHg to 9.7±3.6mmHg. All patients have only trivial to mild aortic
regurgitation during subsequent follow-up. All of them became asymptomatic on follow-up with
an improvement of NYHA Functional Class 1.25. Permanent pacemakers were implanted in 2
patients (15.4%). 1 patient was noticed to have subclavian artery subtotal occlusion after surgical
repair with successful stenting done. No other complications were noted. The in-hospital and 30day mortality was 0%.
Conclusions: TAVI has developed at an escalating pace with rapid adoption world-wide and it is
a feasible alternative for elderly symptomatic AS patients who are deemed inoperable or high-risk
for open heart surgery. We have shown very promising intermediate-term outcome results in Hong
Kong. This involves multi-disciplinary team collaboration and meticulous procedural details to
achieve the optimal results. Long-term outcomes should be diligently monitored.

33.

32.

Candida Infective Endocarditis: Report of 22 Cases From a Prospective Single-center
Study
X.L. Sun1, G.G. Wang1, J. Zhang1
1
Fuwai Hospital, National Center for Cardiovascular Disease, Peking Union Medical
College and Chinese Academy of Medical Science, Beijing, China
Purpose: Fungal infective endocarditis is a rare and poorly understood complication of
fungemia. Most epidemiologic data are derived from case reports. This study was conducted
to explore the clinical characteristics, treatment patterns, and outcomes of patients with
Fungal IE.
Methods: We conducted a prospective, observational study in the Fuwai Hospital,
National Center for Cardiovascular disease, including all consecutive patients with a
definite diagnosis of IE admitted from January 2002 through December 2011. The overall
characteristics and risk factors for death from CE were analysed.
Result: The mean age at presentation was 32 ± 6 years, with a slight male preponderance.
Fourteen of 22 cases (64%) occurred within 1 year of prosthetic valve placement, 6 cases
(27%) of native valve endocarditis (NVE), 2 cases of pacemaker endocarditis. None of
them were intravenous drug users. Most patients (82%) had healthcare-associated IE. The
aortic valve was most commonly affected, and the most common aetiological agent was
Candida species, followed by Histoplasma capsulatum. Persistent infection (75%), major
vessel embolism (61%), and anemia (44%) were the most frequently manifestations. Major
complications occurring during the acute infective phase were also recorded, including
renal dysfunction (75%), such as renal infarction, heart failure (44%), and neurological
complication (38%). Eight patients (36%) underwent valve replacement. Pathological
evaluation of valve material was of high yield, with organisms identified in 87% of cases
who underwent valve replacement surgery. The overall hospital mortality rate was 66.7%.
Mortality was higher in patients with PVE (9 of 14 cases, 64.3%) than in patients with NVE
(2 of 6 patients, 33.3%). A better outcome was observed in patients treated with a combined
medical and surgical therapy.
Conclusion: Fungal infective endocarditis is associated with a high mortality despite
diagnostic and therapeutic improvements. Early diagnosis and transesophageal
echocardiography may be essential for fungal infective endocarditis.

34.

A multidisciplinary approach to improve patient outcome for non-cardiac surgery –
cardiologists’ perspective
YipW.C.1, B. Yan4, Man S.Y.1, Kong C.M.1, Kwong N.P.1, Hau W.Y.1, Tam K.M.1 ,Wai Y.L.2,
Ma K.H.3, Kwan W.K.1
1
Department of Medicine, 2Orthopaedic Surgery, 3ENT Surgery of Yan Chai Hospital &
Cardiology, Prince of Wales Hospital 4Chinese University of HK

Activation and Recoupling of eNOS Underlie the Effect of AVE3085: Endothelial
Protection Against Asymmetric Dimethylarginine
Q Yang1, H.M. Xue1, M.J. Underwood2, C.M. Yu1
1
Division of Cardiology, Department of Medicine and Therapeutics
2
Division of Cardiothoracic Surgery, Department of Surgery; Prince of Wales Hospital, The
Chinese University of Hong Kong, Hong Kong

Introduction: Elderly patients with multiple co-morbid diseases are prone to suffer from
cardiovascular diseases and peri-operative complications arise with poor surgical outcomes.
Objectives: 1.To share the experience of a multidisciplinary approach in patient care. 2.To
enhance awareness of new option in cardiovascular interventions for pre-operative care of
non-cardiac surgery
Methodology: 3 patients suffered from cardiovascular diseases who were admitted into
Yan Chai Hospital between 2010 and 2012 are reviewed. Their pre-operative risks were
assessed and outcomes were documented.
Results: Patient 1 – Mdm. Lam, 70 years old, had history of DM & L. BKA in 2007. She
was admitted for R foot gangrene in Aug. 2010. Peripheral revascularization was performed
at PWH for R Superficial Femoral Artery 90% long lesion & R Anterior Tibial Artery total
occlusion. Patient subsequently had ray amputation (foot preservation) in Sept. 2010 but
re-angioplasty with drug eluting balloon was required and performed for wound healing
again in Dec. 2010. She is now able to walk unaided with L. leg prosthesis. Patient 2 – Mr.
Chow, 66 years old, had history of COPD & NSTEMI/APO in 2010 when he was advised
medical treatment at another hospital. He was diagnosed to have ca larynx for emergency
tracheostomy in Aug. 2011and urgent c.c. & PCI suggested prior to tracheostomy for
LM/LAD & RCA. Both PCI and tracheostomy were uneventful within the same week.
(clopidogrel omitted once for tracheostomy). Despite successful radiotherapy and closure
of tracheostomy, he died of brain & lung metastases in late Mar. 2012. Patient 3 – Mdm.
Tsang, 83 years old, had history of hypertension and recent GIB requiring placation of
bleeder in Oct, 2011. It was complicating with NSTEMI and medical treatment was
advised. She was admitted for R hip fracture in Jan. 2012.High risk orthopedic surgery was
strongly advocated by both patient and surgeons. After thorough discussion for the surgical
risk, PCI was performed for LAD and patient has early hip surgery performed as requested
by patient & relatives. She is having ambulatory exercise at rehabilitation facility.
Conclusion: Strategic planning and collaboration among different specialists help in
improving patient outcome for non-cardiac surgery.

Purpose: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of eNOS and
is recognized as a risk factor for endothelial dysfunction in cardiovascular diseases. We
investigated the effect of AVE3085, a newly developed transcription enhancer of eNOS, on
ADMA-induced endothelial dysfunction in coronary arteries with underlying mechanisms
explored.
Methods: Porcine coronary small arteries (diameter 600-800 µm) were studied in a
myograph for endothelium-dependent relaxation to bradykinin and endothelium-independent
relaxation to sodium nitroprusside. Protein expressions of eNOS, phosphorylated-eNOS
(p-eNOSSer1177 and p-eNOSThr495), and nitrotyrosine were determined by Western blot. NO
release was directly measured with a NO microsensor and O2.- production was determined
by lucigenin-enhanced chemiluminescence.
Results: Exposure to ADMA significantly decreased the bradykinin-induced vasorelaxation
and reduced the protein expression of p-eNOSSer1177 whereas increased the expression of
p-eNOSThr495 and nitrotyrosine. Pre-incubation with AVE3085 restored the bradykinininduced relaxation, reversed the decrease of p-eNOS Ser1177, and lowered the level of
p-eNOSThr495 and nitrotyrosine. NO release in response to bradykinin was significantly
reduced by ADMA and such reduction was restored by AVE3085. AVE3085 also prevented
the elevation of O2.- level in coronary arteries exposed to ADMA.
Conclusions: AVE3085 prevents ADMA-induced endothelial dysfunction in coronary
arteries. The protective effect of AVE3085 may be attributed to increased NO production
resulting from enhanced eNOS activation, and decreased oxidative stress that involves
inhibition of O 2.- generation by eNOS recoupling. The present study suggested the
therapeutic potential of AVE3085 in endothelial dysfunction in cardiovascular disorders.
Acknowledgements: This study was supported by Hong Kong RGC grant (GRF4789/09M)
and CUHK Direct grant 2041688.
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The Impact of Propofol-Dezocine Combination Anesthetic for Painless Induced
Abortion on Cardiovascular System
Fu Hong1, Hu Yan Jun2, Woo Kam Sang3, Wei An-ning4
1
The First Hospital of Chongqing Department of Anesthesiology, Zhongyi Hospital of
Chongqing
2
The Nineth Affiliated Hospital of Chongqing
3
The Chinese University of Hong Kong
4
The Second Affiliated Hospital, Chongqing University of Medical Sciences, Chongqing,
China
Introduction: Induced abortion is practiced frequently in China for medical and other
indications. Intravenous propofenol and dezocine are potent anesthetics for surgical
procedures.
Objective: To observe the impact of propofol combined with dezocine administration for
painless induced abortion on hemodynamics of patients.
Patients and Methods: 116 cases of pregnant women scheduled for induced abortion
were selected randomly. Their mean arterial pressure (MAP),heart rate (HR) and heart rate
variability (HRV) were measured before(T0) and 5 minutes after intravenous dezocine (0.1
mg per kg) (T1), 5 minutes after intravenous propofol (2 mg per kg) (T2) and at the end of
the induced abortion (T3).
Results: Their MAP, and HR at T1 were significantly higher than T0(P<0. 05). MAP, HR
and HRV (low/ high frequency) at T2 were lower than those in T1 (P<0. 01). All parameters
recovered at T3 but were still lower than T1 (P<0. 05). All hemodynamic parameters at
T2 and T3 had no significant difference compared with T0(P ＞ 0. 05). Good sedative and
analgesic effects were witnessed in all patients.
Hemodynamic changes after injection of dezocine and propofol
Variables
T0
MAP (mmHg) 88.0±14.0
HR (bpm)
LF

73.0 ±12.0
1005.0±395.0

T1
112.0±18.0△
86.0±17.0△

T2
79.0±17.0▲▲

T3
93.0±17.0▲

68.0±12.0▲▲

72.0±14.0▲

1720.0±337.0

998.0±415.0

1100.0±492.0▲

493.0±385.0

506.0±313.0

2.0±1.1▲▲

2.2±1.6▲

HF

524.0±316.0

573.0±297.0

LF/HF

1.9±1.1

3.0±1.2△

△

▲▲

Values are the mean ± SD of 116 experiments. LF: Low frequency HF: High frequency
Compared with T0 △p<0.01; compared with T1 ▲P ＜ 0.05, ▲▲P ＜ 0.01
Conclusion: Propofol combined with dezocine in induced abortion is relatively safe,with
no significant impact on hemodynamics, but good sedative and analgesic effects.
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Iron Overload Induces Mitochondria-Dependent Apoptosis and Calpain-Dependent
Titin Proteolysis of Cardiomyocytes
Meipian Chen1, Godfrey C. F. Chan1, Yiu-fai Cheung1
1
Department of Paediatrics and Adolescent Medicine, LKS Faculty of Medicine, The
University of Hong Kong

The Central Role of Transcription Factor Islet-1 in the Gene Regulatory Network of
Histone Acetylation During Embryonic Heart Development
Kong Juanjuan1, Chen guozhen1, Sun huichao1, TianJie1
1
Dept. of Cardiology; Chongqing Medical University of Children’s Hospital, Chongqing, P.R
China

Background & Objectives: Cardiomyopathy secondary to iron overload is well documented
in patients with beta-thalassaemia major. Nonetheless, the underlying mechanisms of iron
entry into cardiomyocytes and the subsequent detrimental effects on cardiac function remain
to be defined. We hypothesized that iron overload contributes to cardiac dysfunction by
inducing apoptosis via mitochondria-dependent pathway, and alters the properties of the giant
myofilament protein titin.
Materials & Methods: Iron-overloaded HL-1 cardiomyocytes, derived from a spontaneously
contracting mouse atrial cell line, were used for in vitro studies; iron-overloaded B6D2F1
mice were used for in vivo studies. Using fluorescent probes, iron was visualized dynamically
and quantitatively in living HL-1 cardiomyocytes by fluorescence microscopy and
quantitative fluorimetry. Using flow cytometry, phosphatidylserine exposure, active caspase-3
expression and mitochondrial membrane potential were determined in Iron-overloaded HL-1
cardiomyocytes. Immunostaining and gel electrophoresis of titin were examined in the heart
tissues of Iron-overloaded mice. Activation of the upstream calcium-dependent protease of
titin, calpain, was detected by FRET substrate cleavage using quantitative fluorimetry.
Results: We demonstrated the uptake of labile iron from culture medium to HL-1
cardiomyocytes. With intracellular accumulation of iron, HL-1 cells showed dose-dependent
lost of membrane integrity, dose-dependent increase of caspase-3 activity and dose-dependent
drop in mitochondrial membrane potential. In the cardiac tissue of Iron-overloaded mice,
calpain activity increased significantly and titin disarray and degradation were also observed.
Conclusion: Our findings suggest that iron overloading, through activation of calpain, causes
titin proteolysis, and induces mitochondria-mediated caspase-3 dependent apoptosis in
cardiomyocytes, which results in cardiac dysfunction.

Objective: To investigate the temporal expression of transcription factor Islet-1 and the
central role of transcription factor Islet-1 in the gene regulatory network during the embryonic
heart development.
Methods: The whole hearts from newborn mice and embryonic mice on embryonic days
11.5 (E11.5), E14.5, and E17.5 were collected respectively. The temporal expression of the
transcription factor Islet1 was quantitative detected by Western-blot method. The transcription
factor Islet-1 was determined using p300 primary antibody with co-immunoprecipitation (CoIP) and subsequent mass spectrum (MS) analysis, meanwhile the relationship between Islet-1
and histone acetyltransferase p300 was negative verified by Western-blot assay. Cardiacspecial genes , such as GATA4, Mef2c and Tbx5 that physically interacted with Islet-1 protein
, were analyzed using chromatin immunoprecipitation (ChIP) assays and Q-PCR.
Results: (1) The data from Western-blot assay revealed that the expression of the transcription
factor Islet-1 reached a peak on day E14.5, and then was gradually decreased afterward during
embryonic heart development. The expression of transcription factor Islet-1 was significantly
higher in the group on E14.5 (0.434±0.353) than other groups on E11.5 (0.074±0.456),
E17.5 (0.120±0.127) and newborn mice (0.049±0.083) (p<0.05), but there was no significant
difference among E11.5, E17.5 and newborn mice (p>0.05). (2) Results from Co-IP 、MS and
Western-blot assays showed that the transcription factor Islet-1 could combine with histone
acetyltransferase p300 to form complex protein during the embryonic heart development. (3)
Results from ChIP assay showed that Islet-1 protein physically conbined with the promoter
region of cardiac-specific genes (GATA4, Mef2c and Tbx5).
Conclusion: Islet-1, as a central role, may recruit histone acetyltransferase p300 and conbine
with the promoter region of cardiac-specific genes (GATA4, Mef2c and Tbx5) during the
embryonic heart development.

38.

39.

BMP2 increase the expression of cardiac transcription factors via up-regulating histone
H3 acetylation in H9C2 cells
Min Zheng1, Jie Tian1
1
Children’s Hospital of Chongqing Medical University, Chongqing, P.R. China

ISLET-1 Assist Histone Acetylation to Regulate Cardiac Development-Related
Transcription Factors
Zhongsu Yu1, Jie Tian1
1
Children’s Hospital of Chongqing Medical University, Chongqing, P.R. China

Objective: During the induction of cardiac myogenesis,BMP2 elicits expression of cardiac
transcription factors such as Nkx2.5 and Gata4, but the underlying mechanisms are not clear.
Our previous study suggests that histone acetylation play an important role in the regulation
of gene expression during heart development. The regulation of histone acetylation may be
a mechanism by which BMP2 increase the cardiac transcription factors expression. The goal
of current study is to investigate the effect of BMP2 on cardiac transcription factors (GATA4,
MEF2C) and histone H3 acetylation in H9C2 cells.
Material and Method: The cultured rat H9C2 embryonic cardiac myocytes were transfected
with pAdEasy-BMP2 adenovirus（AdBMP2）. Transfection efficiency was measured by
flow cytometry. the mRNA expression level of BMP2,GATA4,MEF2C, p300 and smad4 were
assessed by quantitative real-time RT-PCR. The histone H3 acetylation level in the promoter
regions of GATA4, MEF2C were assessed by ChIP. Histone H3 acetylation level and the
smad4 protein content in nucleus were assessed by Western Blotting.
Results:
1.Twenty four hours after transfected with AdBMP2,the transfection efficiency were more
than 90% and the expression of BMP2 were improved significantly.
2.Forty eight hours after transfection, the acetylation of histone H3 in nucleus and in the
promoter regions of cardiac transcription factors GATA4 and MEF2C was up-regulated.
Accordingly ,the expression of these genes were significantly increased.
3.BMP2 also increased the mRNA expression level of p300 and smad4 ,and the smad4
protein content in nucleus.
Conclusion: Taken together, the increase of cardiac transcription factors GATA4 and MEF2C
expression by BMP2 partly via up-regulating the histone H3 acetylation level associated
with those gene promoter region. The histone acetylases subtype p300 and smad4 signaling
pathway may take part in the BMP2 induced histone hyperacetylation.
Keywords: BMP2; histone acetylation; p300; smad4; cardiac transcription factors

Objective: Histone acetylation is a important epigenetic method. Our previous studies
showed that cardiac development-related transcription factors were regulated by histone
acetylation. Histone acetylation level depends on histone acetyltransferases (HATs) and
histone deacetylase (HDACs). However, HATs have no DNA binding domain. They need a
assistant factors to combine with DNA. The LIM-Homeodomain transcription factors Islet-1
is a important transcription factors during cardiac development. It may be the assistant factors.
This study investigated whether Islet-1 assisted histone acetylation to regulate the expression
of cardiac development-related transcription factors via a cardiac progenitor cell model which
was transfected lentivirus with a Islet-1 RNAi vector.
Material and Method: Cardiac progenitor cells that were transfected with lentivirus vectors
to inhibit Islet-1 expression served as RNAi group. The cardiac progenitor cells that were
transfected with empty vectors served as negative control. Transfection efficiency was
measured by flow cytometry. The expression of cardiac development-related transcription
factors were measured using Q-PCR. Histone acetylation level was detected by western
blotting. Cardiac development-related transcription factors that physically interacted with
acetylated histone H3 in cardiac progenitor cells were analyzed using ChIP assays. Cardiac
development-related transcription factors that physically interacted with p300 in cardiac
progenitor cells were analyzed using ChIP assays.
Results 1. Flow cytometry showed that transfection efficiency of negative control and RNAi
group were both more than 30%. Q-PCR result showed that the expression of Islet-1, Mef2c
and Tbx5 at RNAi group were less than blank control and negative control (p<0.05). However,
there are no significant difference of the expression of Gata4 at RNAi group compared to
control groups (p>0.05). 2. Western blotting showed that there were no significant difference
of histone H3 acetylation level at RNAi group compared to control groups (p>0.05). ChIPPCR assays revealed that histone H3 acetylation level of Mef2c promter at RNAi group
was less than control groups (p<0.05), and there were no significant difference of histone
H3 acetylation level of Gata4 promter and Tbx5 promter. Meanwhile, binding level of p300
to Mef2c promter at RNAi group was less than control groups (p<0.05). There were no
significant difference of binding level of p300 to Gata4 promter and Tbx5 promter.
Conclusion: These data indicated that Islet-1 can assist p300 to combine with Mef2c promter,
and increase histone H3 acetylation level of Mef2c promter to activate expression of Mef2c.
However, histone acetylation may regulate expression of Gata4 and Tbx5 through other
method.
Keywords Islet-1; histone acetylation; transcription factors; cardiac progenitor cell; cardiac
development
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Resting Heart Rate is associated with Blood Pressure, Adiposity and Intensity of
Exercises in Children
S.Y Kwok1, H.K So1, A.F.C. Lo1, R.Y.T. Sung1
1
Department of Paediatrics, The Chinese University of Hong Kong, Prince of Wales
Hospital, Shatin, Hong Kong
Background: Resting heart rate (RHR) is a readily measurable triage parameter in
acute paediatric medicine. In adults, there is a correlation between increased RHR and
cardiovascular risk and accumulating evidences showed this may also be true in children.
The purpose of this study was to analyze the association between RHR, blood pressure (BP)
and adiposity in children, and whether lifestyle modification could help in reducing RHR.
Methods: Data analyzed in this study was obtained from a territory-wide growth study
carried out in 2005-2006. Students were randomly selected from each of the 18 districts of
Hong Kong and had their RHR and BP measured by a validated oscillometric BP device.
Their anthropometric data were recorded. Students who were grade 4 or above were further
asked to report their frequencies of participation in structured exercise programs. The
percentiles of RHR by age and gender using LMS method were generated. Analysis of
Variance (ANOVA), Pearson Chi-square test and multiple linear regression analysis were
used to test associations between RHR and BP, anthropometry and exercise frequency.
Structural equation modeling (SEM) technique was used to further test the association
between obesity and RHR.
Results: A total of 14842 Chinese school children aged 6-18 years were included. Sex
specific reference values and percentile curves for RHR were attained. Higher RHR were
found in girls, and groups of young or obese children. With multiple linear regression
analysis, there was a significant association between high RHR and elevated BP in children,
which were independent of adiposity. (p<0.001) On the other hand, RHR had a negative
association with age. (p < 0.001) An inverse relationship between RHR and exercise
frequency was observed, and RHR was substantially decreased with increased training
frequency. (p < 0.001). There was a weak positive association between RHR and obesity. (p
< 0.001 for boys; p = 0.002 for girls)
Conclusions: Elevated RHR has a clear and independent link to elevated BP and high
adiposity. Structured physical training activity has a beneficial effect on RHR
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Nonfluoroscopic Approach for Cryoablation of Atrioventricular Junctional Reentry
Tachycardia in Children and Young Adults Using a Three-Dimensional Navigation
System
T.C. Yung1, K.S. Lun1, K.T. Wong1, P.C. Chow1
1
Department of Paediatric Cardiology, Queen Mary Hospital, Hong Kong, China
Background & Objectives: Three-dimensional mapping allows continuous visualization
of the locations of electrode catheters, and has the potential to decrease fluoroscopy
times. The aim of this study was to assess the impact of the new mapping system on the
fluoroscopy use during cryoablation of atrioventricular junctional reentry tachycardia
(AVJRT) in children and young adults.
Methods: From Feburary 2010 to November 2011, 28 patients (age: 14.2±4.0 years) with
AVJRT underwent transcatheter cryoablation, with catheter navigation and mapping guided
by the EnSite NavX system (St. Jude Medical, USA)(NavX group). Fluoroscopy times and
procedure times were compared retrospectively to 18 cryoablation cases (age: 15.7± 3.2
years) for AVJRT using fluoroscopy only(control group).
Results: Mean procedure time was similar in both groups (NavX 174.2±38.5 minutes vs
control 172.3±47.6 minutes). Mean fluoroscopy time in the NavX group was 8.2 ± 10.8
minutes (range 0- 44.5), which is significantly reduced when compared to the control
(30.7±13.3 minutes) (p< 0.05). In the NavX group fluoroscopy time in the last 7 cases was
less than one minute. Three procedures did not require fluoroscopy and one procedure
recorded only 2 seconds of fluoroscopy. Procedural success was achieved in 27 (96%) cases
of the NavX group and 100% in the control group.
Conclusion: Three-dimensional mapping by the Ensite NavX system effectively decreased
fluoroscopy use during transcatheter cryoablation for AVJRT in children and young adults.

43.

Experimental study on preparation and characteristics of HSA modified paclitaxelcarrying nanometre microbubbles
R. Yang1, X. Ji1, J. Tian1
1
Department of Cardiology, Children’s Hospital of Chongqing Medical University
Purpose: To prepare paclitaxel-carrying nanometre microbubbles(PNM) modified with
human serum albumin(HSA) and study the Characteristics.
Methods: The HSA modified PNM was prepared by thin-film dispersion method and
mechanical vibration, the appearance,concentration,mean diameter,zeta potential and the
entrapment efficiency were detected. The normalrabbit’s iliac artery contrast imaging was
observed.
Results: This modified PNM had a good shape.The mean diameter was(772.9±6.2)nm,
the concentration of bubble was (8.64±1.38)×10 /ml, zeta potenital was(-13.2±0.3)mv, the
entrapment efficiency of the modified bubble was (93.51±2.07)%,which washigher than
that of no modified bubble (84.88±4.14)%(P<0.05).It could make the rabbit iliac artery
enhancement.
Conclusions: The HSA modified PNM was stable and effective, with smaller sizeand
higher encapsulation efficiency.
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42.

Pulmonary Artery sling: a Rare Cause of Respiratory Distress in Infants and Children
J. Hou1, F. Liu1, L. Wu1, Y.H. Gui1, Q.L. Shen1
Children’s Hospital of Fudan University, Shanghai, China

1

Background: Pulmonary artery sling (PAS), a rare congenital cardiac anomaly, may cause
non-specific respiratory distress in infants and children, and lead to be misdiagnosed.
The aim of this report was to clarify the clinical and imaging features of this entity and
emphasize the role of imaging in defining the anatomy and important associated anomalies.
Methods: Twelve consecutive patients (6 boys and 6 girls, aged from 15 days to 82 months)
were diagnosed as PAS in our hospital from January 2003 to September 2011. Their
symptoms, diagnostic findings, treatments, and outcomes were retrospectively reviewed.
Results: Eleven patients (92%) had respiratory distress, with the age at onset from 1 day
to 24 months. Echocardiography failed to diagnose PAS in 3 patients. Eight patients (67%)
had associated cardiac malformations, including persistant left superior vena cava(3), left
patent ductus arteriosus(3), right pulmonary artery stenosis(3), ventricular septal defect(2),
atrial septal defect (2), coarctation of the aorta (1), and tetralogy of Fallot (1).Ten patients
who had multidetector CT (MDCT) were all diagnosed as PAS and were classified as type
IA PAS in 2 cases, type IIA in 3 cases and type IIB in 5 cases and all these 10 patients
were diagnosed as various degree tracheal bronchus stenosis. Cardiac catheterization and
angiography in 4 patients with complex cardiac malformations showed cardiovascular
anatomy as well as PAS. Six patients had surgical repair of PAS and associated cardiac
anomalies. One patient died shortly after surgery. Two patients without surgical repair died
of severe respiratory infection during follow-up in their first year.
Conclusion: Patients with recurrent stridor and wheeze should be examined for the possible
presence of PAS. Echocardiography is helpful for the diagnosis of PAS and associated
cardiac anomalies. MDCT with 3-dimensional reconstruction can clearly demonstrate the
anatomy of pulmonary artery and trachea stenosis, and is valuable in the classification
and therapeutic consideration. Except for complex cardiovascular malformaltions, cardiac
catheterization is unnecessary for PAS patients.

44.

Paclitaxel-Carrying Liposome Microbubbles Combining with Low-Frequency Focal
Ultrasound Inhibits Neointimal Hyperplasia in a Rabbit Iliac Balloon Injury Model
J. Guo1, X.J. Ji1, G.S. Yu1, et al
1
Department of Cardiology, The Children’s Hospital of Chongqing Medical University,
Chong Qing, P.R. China
Objective: To evaluate the effect of paclitaxel-carrying liposome microbubbles (PLM)
combining with low-frequency ultrasound on vascular reconstruction, a rabbit iliac balloon
injury model was used.
Methods: 25 young New Zealand White rabbits were subjected to iliac balloon injury
for induction of iliac stenosis. 3 weeks after surgery, animals were randomly divided
into 5 groups and underwent treatment for 7 days as: Group A: PLM plus low-frequency
ultrasound (PLM+US), Group B: liposome microbubbles plus low-frequency ultrasound
(LM+US), Group C: PTX plus low-frequency ultrasound (PTX+US), Group D: lowfrequency ultrasound only (US) and Group E: no treatment control group (BC). The lowfrequency ultrasound focally targeted the injured iliac arteries. Animals were sacrificed 7
days after treatment for histological and pathological analysis.
Results: The vascular structures reconstruction with the elastic fiber hyperplasia in the
lining layer was observed obviously after 3 weeks of the surgery. The intima area and the
tunica media area were the largest in group E（P<0.05）.The lumen area was largest but
the intima area and the tunica media area were the lowest in group A（P=0.000）. The
ratio of the intima area and tunica media area were reduced after the intervention（P<0.05）,
especially in group A（P=0.000）.In group A , the positive cells was significantly Less
than the other intervention groups (P<0.05) .
Conclusion: Paclitaxel-carrying liposome microbubbles combining with low-frequency
focal ultrasound significantly inhibits neointimal hyperplasia. Paclitaxel-carrying liposome
microbubbles combining with low-frequency focal ultrasound may represent a novel
therapeutic method for treating restenosis.
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Establishment of Pulmonary Hypertension and Right Ventricular Dysfunction Model
in the Beagle Induced by Dehydromonocrotaline
J. Lam1
1
Department of Pediatric Cardiology, the First Affiliated Hospital, Sun Yat-sen University,
China

The use of covered Cheatham-Platinum stent for native coarctation of the aorta in
children: A report of two cases
Y. Li1
1
Department of Pediatric Cardiology, The first affiliated hospital, Sun Yat-Sen University,
Guangzhou 510000, China

Purpose: To explore the way and technique to establish pulmonary hypertension and right
ventricular dysfunction model in the beagle using dehydromonocrotaline.
Methods: Fifteen beagle dogs were randomly divided into three groups, the control
group(n=5) the peripheral vein injecting group(the PV group)(n=4)and the right
ventricle injecting group(the RV group)(n=6). Monocrotaline was transformed into
dehydromonocrotaline in vitro. After the hemodynamicdatas including the mPAP, PVR, CO
were obtained, the PV group were injected dehydromonocrotaline 2.5y3.5mg/kg dissolved
in dimethylformamide(0.1ml/kg) via veins of right upper extremity, the RV group were
injected dehydromonocrotaline 3.5y4.0mg/kg dissolved in dimethylformamide(0.1ml/kg)
via right ventricle. Hemodynamic measure was repeated after six weeks and pathological
autopsy was performed after the beagle died.
Results: 1 The dehydromonocrotaline was extremely unstable and sensitive to water
and temperature. 2 Four beagle of the PV group and there of six beagle of the RV group
survived after six weeks. Two dogs injected dehydromonocrotaline 2.5mg/kg via the
peripheral vein way failed to set up pulmonary hypertension and right ventricle dysfunction
model. Two dogs injected dehydromonocrotaline 4.0mg/kg via the right ventricle way
died of pulmonary edema within 48hours and and one dog injected dehydromonocrotaline
3.5mg/kg died on the 32th day after injection. All the other beagles alive were successful
to establish pulmonary hypertension and right ventricular dysfunction. The mPAPyPVR
were significantly increased in the dehydromonocrotaline injection groups. And the changes
in control group did not show statistic significance. 3 Hypertrophy and proliferation
of pulmonary vascular smooth muscle, narrowing of the lumens and infiltration of
inflammatory cells were observed under light microscope in the dyhydromonocrotaline
injecting groups.
Conclusion: 1 The dehydromonocrotaline was extremely unstable and should be injected as
soon as possible after transformation from monocrotaline in vitro.
2 It was successful to establish pulmonary hypertension and right ventricular
dysfunction model in the beagle via the peripheral vein or the right ventricle way using
dehydromonocrotaline.
3 The effective dose and lethal dose of dehydromonocrotaline was very close and it was
easily to cause death when applying above the dose of 3.5mg/kg

Purpose: To evaluate the short-term effect of covered Cheatham-Platinum (CP) stent
implantation in children with native coarctation of the aorta(CoA).
Methods: From July to December 2010,2 male patients with native CoA underwent covered
CP stent implantations in our institute. The covered CP stents were delivered to the CoA
site through the balloon catheters, both of which were selected according to the data of
aortogram ,using a retrograde femoral artery approach. Inflated the BIB balloon to expand
the stent when the blood pressure dropped by 50% under rapid right ventricular pacing.
Results: The patient age and weight were 11 year,23.8kg and 15 years,42 kg, respectively.
The tran-coarctation pressure gradient before stenting were 63mmHg and 57mmHg
respectively according to the echocardiogram.2 cases were both immediate successful. A
Numed covered CP stent(8Zig x 3.4cm) was implanted in either of the patient,through a
12F sheath and 9F BIB balloon(with an outer balloon of 16mm x 4.0cm).The peak systolic
pressure gradient across the CoA site decreased from 72mmHg,26mmHg to 2mmHg,8mmHg
and the minimum aortic diameter increased from 3mm,4.8mm to 16mm,15mm respectively.
The patients were followed up for 14~ 20 months and the echocardiogram showed that the
tran-coarctation pressure gradient were 20mmHg and 11mmHg respectively, without major
complications including approach artery injury,stent migration,aneurysm formation and
aortic dissection.
Conclusion: Covered CP stents are feasible and safe for native coarctation of the aorta in
children at short-terms. Further observation and follow-up data are still needed to assess
mid-term and long-term safety and efficacy.rtery injury,stent migration,aneurysm formation
and aortic dissection.
Conclusion: Covered CP stents are feasible and safe for native coarctation of the aorta in
children at short-terms. Further observation and follow-up data are still needed to assess
mid-term and long-term safety and efficacy.
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Unveiling the Genetics of Long QT Syndrome: a Local Paediatric Experience
A.P.Y. Lie1, B.H.Y. Chung1, T.C. Yung1
1
Department of Paediatrics & Adolescent Medicine, Queen Mary Hospital, University of
Hong Kong, Hong Kong
Purpose: Genetic testing has emerged to become an indispensable component of standard
clinical management for patients with long QT syndrome (LQTS). Local data on the
genetics of paediatric patients with LQTS are lacking. The current study offers insight into
the underlying mutations of these probands, acts as a pilot study for the implementation of a
multi-disciplinary inherited arrhythmia program.
Methods: We identified patients who were clinically diagnosed to have LQTS from 2006 to
2011 from the database of the Department of Paediatric Cardiology, Queen Mary Hospital.
Relevant demographic and clinical data was retrieved. Pre-test counselling was then
conducted and for patients’ who consented to testing, samples were sent for sequencing
of 6 responsible genes (LQT1-3, 5-7) together with multiplex ligation-dependent probe
amplification analysis of 5 responsible genes (LQT1-3, 5-6).
Results: 16 patients with LQTS underwent genetic testing. Nine were male (56%), the
mean age at diagnosis was 10.9 years (range 0-18 years) and the mean longest corrected QT
interval identified on a standard 12-lead electrocardiogram was 522ms (range 460-619ms).
Syncope was the commonest initial presentation occurring in 9 individuals. Pathogenic
mutations were detected in 9 patients (56%), affecting LQT1 gene in 3, LQT2 in 4, LQT3
in 1 and LQT5 in 1; 2 patients (13%) had likely pathogenic mutations, both in the LQT2
genes; 2 patients (13%) only had variants of unknown clinical significance in the genes
tested and 3 (19%) had no mutation demonstrated.
Conclusions: Our study demonstrated that up to 69% of our LQTS patients have
pathological, or likely pathological mutations of LQT genes. Integration of genetic
assessment with in the management of LQTS is important in diagnosis, risk stratification
and genotype-guided therapy.
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Outcome of Coronary Artery Bypass Grafting in the Modern Era: A Single Institution
Experience
Kwok MWT1, Wong RHL1, Ng CSH1, Yeung ECL1, Wan IYP1, Wan S1, Underwood MJ1
1
Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales Hospital,
Shatin

International Benchmarking of Surgical Outcomes: Globalizing Quality Assurance in
Cardiac Surgery
Kwok MWT1, Wong RHL1, Ng CSH1, Wan IYP1, Wan S1, Underwood MJ1
1
Division of Cardiothoracic Surgery, Department of Surgery, Prince of Wales Hospital,
Shatin

Purpose: To review surgical results of coronary artery bypass grafting in a single
institution.
Methods: We prospectively studied patients underwent coronary artery bypass grafting
(CABG) in Prince of Wales Hospital from 1/2006 to 06/2011. Patients’ demographics,
automatically generated risk scores, intra and post-operative variables were recorded. Data
was prospectively collected and entered for analysis after being validated by a research
assistant.
Results: In the study period, 971 patients underwent isolated CABG in our institution.
Mean age was 63 years old, the mean logistic Euroscore was 3.36 and mean complex
Bayes score was 3.31. There was a male predominance (81.5%) and 49.2% of patients
were diabetics. Since 38.5% of patients had left main coronary artery stenosis and 30.5%
patients had unstable symptoms, we had 35.4% of patients received aspirin at the time of
operation. There were 175 urgent (18%) and 46 emergency operations (4.7%). There were
27.8% of patients with ejection fraction less than 50%. Cardiopulmonary bypass machine
usage and arterial grafts usage were 92.8% and 95.6%, respectively. Post-operative intraaortic balloon usage was 3.9%, ICU readmission rate was 3.4%, reoperation for bleeding
rate was 1.6% and permanent stroke rate was 0.5%. The overall crude mortality rate for
CABG was 1.2 %, crude mortality for elective CABG was 0.5%.
Conclusion: In modern era, CABG is associated with very low morbidities and mortalities
especially when undertaken in the elective setting.

Purpose: Benchmarking is an important component of quality assurance programmes. The
European Society for Cardiothoracic Surgery (ESCTS) Database includes data from over
29 countries in Europe, 50 hospitals from mainland China and outcomes for over 1 million
cardiac procedures. This study shows the outcome benchmarking for the cardiac surgery
activity from our Division (Chinese University of Hong Kong, Prince of Wales Hospital
(CUHK)) with the ESCTS Database, including data from mainland China.
Method: Prospective data collection for all cardiac surgical activity within our Division
was stored in a dedicated server. Data was independently and remotely extracted from this
server by representatives of the ESCTS for the period 2006-8 inclusive. Benchmarking
was performed independently by ESCTS for activity, data completeness and risk-adjusted
outcomes (using
logistic-EuroSCORE) by funnel plot construction. Mortality for all activity and index
procedures (coronary artery bypass grafting (CABG), aortic valve replacement) was
presented with 99% and 99.9% confidence intervals.
Results: CUHK contributed to 3.7% of overall database submissions from Asia. Data
completeness for CUHK ranked number 1 for 8 assessed risk variables (total 12) (range
1-9).There were major differences between Asia, CUHK and European Regions in terms
of preoperative patient characteristics and operative workloads. CUHK mortality for all
activity was 2% (99% CI: 2-5), CABG 1% (99% CI: 0.9-4) and risk-adjusted CABG (logistic
EuroSCORE) 1.5% (99% CI 1-4.2%). CUHK post-operative stay was mean 6.7 days (whole
database 10.0 days, Asian Zone 12.6 days).
Conclusion: We have implemented a computerized data collection and analysis system and
constructed a database for patients undergoing cardiac surgery. We have used this to allow
independent data extraction, analysis and benchmarking by a National Society to provide
evidence of local activity and outcomes compared to standards set in Europe and Asia.
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